PubMed Identification:

Starting with   __   _1   _2   _3   _4   _5   _6   _7   _8   _9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37

PMID
Article Title
Citation
Organization
Download
View Data
Cannabinomimetic lipid from a marine cyanobacterium.EBI
J Nat Prod 74: 2313-7 (2011)
University of California
Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds.BDB
J Enzyme Inhib Med Chem 27: 845-8 (2012)
Ondokuz Mayis University
Development of a bivalent dopamine D2 receptor agonist.EBI
J Med Chem 54: 7911-9 (2011)
Friedrich-Alexander University
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity.EBI
J Med Chem 54: 7834-47 (2011)
Astrazeneca R&D Boston
1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase.EBI
J Med Chem 54: 7899-910 (2011)
RhôNe-Poulenc Rorer
Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.EBI
Bioorg Med Chem 19: 6833-41 (2011)
Kumamoto Health Science University
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site.EBI
Bioorg Med Chem Lett 21: 6646-51 (2011)
Bristol-Myers Squibb Research and Development
Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.EBI
Bioorg Med Chem Lett 21: 6724-7 (2011)
Fudan University
Molecular dynamics simulations and MM/GBSA methods to investigate binding mechanisms of aminomethylpyrimidine inhibitors with DPP-IV.EBI
Bioorg Med Chem Lett 21: 6630-5 (2011)
Graduate University of The Chinese Academy of Sciences
Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.EBI
Eur J Med Chem 46: 5662-7 (2011)
Universidad Europea De Madrid
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands.EBI
Eur J Med Chem 46: 5641-53 (2011)
Sapienza University of Rome
Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as ?-secretase inhibitors.EBI
J Med Chem 54: 7772-83 (2011)
Pfizer
Discovery of N-[2-hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (darexaban, YM150) as a potent and orally available factor Xa inhibitor.EBI
J Med Chem 54: 8051-65 (2011)
Astellas Pharma
Daedalols A-C, fungal-derived BACE1 inhibitors.EBI
Bioorg Med Chem 19: 6581-6 (2011)
University of Hawaii At Manoa
Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties.EBI
J Med Chem 54: 7759-71 (2011)
Sapienza University of Rome
Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen.BDB
ACS Chem Biol 7: 185-96 (2012)
Harvard Medical School
Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents.EBI
J Med Chem 55: 2-22 (2012)
University of Messina
Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.EBI
J Med Chem 54: 7621-38 (2011)
Pfizer
Carbazole-containing arylcarboxamides as BACE1 inhibitors.EBI
Bioorg Med Chem Lett 21: 6657-61 (2011)
Universit£
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.EBI
Bioorg Med Chem Lett 21: 6888-94 (2011)
Kalypsys
A modular approach to trim cellular targets in anticancer drug discovery.EBI
Bioorg Med Chem Lett 21: 6641-5 (2011)
Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
Docking studies of benzylidene anabaseine interactions witha7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of relateda7 selective ligands.EBI
Eur J Med Chem 46: 5625-35 (2011)
Targacept
Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptase.EBI
J Med Chem 54: 7920-33 (2011)
Merck
Rational design of phosphoinositide 3-kinasea inhibitors that exhibit selectivity over the phosphoinositide 3-kinaseß isoform.EBI
J Med Chem 54: 7815-33 (2011)
Genentech
Chromone containing sulfonamides as potent carbonic anhydrase inhibitors.BDB
J Enzyme Inhib Med Chem 27: 744-7 (2012)
Ondokuz Mayis University
Synthesis and biological evaluation of novel N, N'-disubstituted urea and thiourea derivatives as potential anti-melanoma agents.BDB
J Enzyme Inhib Med Chem 27: 708-14 (2012)
Nanjing University
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ┐F508-CFTR.EBI
ACS Med Chem Lett 2: 703-707 (2011)
TBA
In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.BDB
J Biol Chem 286: 40734-42 (2011)
Astrazeneca
Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.EBI
Bioorg Med Chem Lett 21: 6788-92 (2011)
Emory University
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11ß-hydroxydehydrogenase 1 (11ß-HSD1).EBI
Bioorg Med Chem Lett 21: 6693-8 (2011)
Bristol-Myers Squibb Research & Development
Synthesis and structure-activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors.EBI
Bioorg Med Chem Lett 21: 6652-6 (2011)
Biocrea
Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD-1).EBI
Bioorg Med Chem Lett 21: 6699-704 (2011)
Bristol-Myers Squibb
Synthesis and acrosin inhibitory activity of substituted 4-amino-N-(diaminomethylene) benzenesulfonamide derivatives.EBI
Bioorg Med Chem Lett 21: 6674-7 (2011)
Second Military Medical University
9,10-secosteroids, protein kinase inhibitors from the Chinese gorgonian Astrogorgia sp.EBI
Bioorg Med Chem 19: 6873-80 (2011)
Peking University
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors.EBI
Bioorg Med Chem 19: 6949-65 (2011)
The Institute of Cancer Research
Discovery of new orally active prostaglandin D2 receptor antagonists.EBI
Bioorg Med Chem 19: 6935-48 (2011)
Ono Pharmaceutical
Identification of a novel RAMP-independent CGRP receptor antagonist.EBI
Bioorg Med Chem Lett 21: 6705-8 (2011)
Merck Research Laboratories
7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.EBI
Bioorg Med Chem Lett 21: 6687-92 (2011)
Cylene Pharmaceuticals
A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action.EBI
Bioorg Med Chem Lett 21: 6714-23 (2011)
Qatar University
Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype.EBI
Bioorg Med Chem Lett 21: 6739-45 (2011)
The Scripps Research Institute
Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.EBI
Bioorg Med Chem Lett 21: 6800-3 (2011)
Pfizer
The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.EBI
Bioorg Med Chem Lett 21: 6782-7 (2011)
Monash University (Parkville Campus)
Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.EBI
Eur J Med Chem 46: 5473-9 (2011)
Comsats Institute of Information Technology
Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer.EBI
J Med Chem 54: 7579-87 (2011)
Genentech
Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysis.BDB
J Enzyme Inhib Med Chem 27: 800-9 (2012)
Slovak University of Technology
Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.EBI
Bioorg Med Chem 19: 6182-95 (2011)
University of Hawaii At Hilo
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer.EBI
Bioorg Med Chem 19: 6383-99 (2011)
Takeda Pharmaceutical
Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 6793-9 (2011)
Celgene
Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.EBI
Bioorg Med Chem Lett 21: 6824-8 (2011)
Chungnam National University
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.EBI
Bioorg Med Chem Lett 21: 6767-9 (2011)
Menarini Ricerche Pomezia
Synthesis and radioligand binding studies of bis-(8-isopropyl-isoquinolinium) derivatives as ligands for apamin-sensitive sites on cloned SK2 and SK3 channels.EBI
Bioorg Med Chem Lett 21: 6756-9 (2011)
University of Li£Ge
Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.EBI
Bioorg Med Chem Lett 21: 6852-5 (2011)
Itherx Pharmaceuticals
Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA).EBI
Bioorg Med Chem Lett 21: 6760-6 (2011)
University of Wollongong
Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixedµ/d opioid receptor agonistic properties.EBI
J Med Chem 54: 7848-59 (2011)
Vrije Universiteit Brussel
Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.EBI
Bioorg Med Chem 19: 6261-73 (2011)
Takeda Pharmaceutical
Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C.EBI
Bioorg Med Chem 19: 6196-202 (2011)
University of Houston
Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.EBI
Bioorg Med Chem 19: 6203-9 (2011)
The Scripps Research Institute
Synthesis and characterization of [¹²¿?¿I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.EBI
Bioorg Med Chem 19: 6245-53 (2011)
Nagasaki University
Identification of novel NK1/NK3 dual antagonists for the potential treatment of schizophrenia.EBI
Bioorg Med Chem Lett 21: 6899-904 (2011)
Glaxosmithkline
AHL-dependent quorum sensing inhibition: synthesis and biological evaluation ofa-(N-alkyl-carboxamide)-¿-butyrolactones anda-(N-alkyl-sulfonamide)-¿-butyrolactones.EBI
Bioorg Med Chem Lett 21: 6876-9 (2011)
Insa Lyon
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.EBI
Bioorg Med Chem Lett 21: 6909-15 (2011)
Bristol-Myers Squibb Research and Development
A fluorescent probe for GM1 gangliosidosis relatedß-galactosidase: N-(dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol.EBI
Bioorg Med Chem Lett 21: 6872-5 (2011)
Industrial Research
Discovery of a new class of glucosylceramide synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 6773-7 (2011)
Exelixis
Introduction of an electron withdrawing group on the hydroxyphenylnaphthol scaffold improves the potency of 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) inhibitors.EBI
J Med Chem 54: 7547-57 (2011)
Saarland University
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.EBI
J Med Chem 54: 7206-19 (2011)
Sanofi-Aventis Research and Development
Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.EBI
J Med Chem 54: 7184-92 (2011)
Vertex Pharmaceuticals
Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues.BDB
J Biol Chem 286: 40867-77 (2011)
Millennium Pharmaceuticals
Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.EBI
Eur J Med Chem 46: 5227-36 (2011)
Katholieke Universiteit Leuven
Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group.EBI
Bioorg Med Chem 19: 6274-84 (2011)
Cephalon
Identification of a potent and selectives¿? receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells.EBI
Bioorg Med Chem 19: 6210-24 (2011)
University of Pavia
Novel orally active antimalarial thiazoles.EBI
J Med Chem 54: 7713-9 (2011)
University of Cape Town
Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade.EBI
J Med Chem 54: 7567-78 (2011)
University of Maryland
Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinEBI
J Med Chem 54: 7639-47 (2011)
Vanderbilt University Medical Center
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.EBI
Drug Metab Dispos 40: 130-8 (2011)
Astrazeneca
Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.EBI
Bioorg Med Chem Lett 21: 6842-51 (2011)
Boehringer Ingelheim Pharmaceuticals
Identification of 4-quinolone derivatives as inhibitors of reactive oxygen species production from human umbilical vein endothelial cells.EBI
Bioorg Med Chem Lett 21: 6861-6 (2011)
Astellas Pharma
Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.EBI
Eur J Med Chem 46: 5549-55 (2011)
Sun Pharma Advanced Research
Oligopeptide cyclophilin inhibitors: a reassessment.EBI
Eur J Med Chem 46: 5556-61 (2011)
Max Planck Research Unit For Enzymology of Protein Folding
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists.EBI
Bioorg Med Chem 19: 6454-73 (2011)
University of Basel
Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novels1 receptor PET imaging agent.EBI
Bioorg Med Chem Lett 21: 6820-3 (2011)
The University of Sydney
Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2.EBI
Bioorg Med Chem Lett 21: 6833-7 (2011)
Xiamen University
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case.EBI
Bioorg Med Chem Lett 21: 6867-71 (2011)
University of Siena
Characterization of a novel and selective CB1 antagonist as a radioligand for receptor occupancy studies.EBI
Bioorg Med Chem Lett 21: 6856-60 (2011)
Bristol-Myers Squibb
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.EBI
Bioorg Med Chem 19: 6518-24 (2011)
Nanjing University
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent ?4?2 nicotinic acetylcholine receptor ligands.EBI
J Med Chem 54: 7678-92 (2011)
Abbott Laboratories
Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.EBI
J Med Chem 54: 7558-66 (2011)
Monash University
Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.EBI
Bioorg Med Chem 19: 6340-7 (2011)
Universiti Putra Malaysia
Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.EBI
Bioorg Med Chem 19: 6316-28 (2011)
National Taiwan University
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.EBI
Bioorg Med Chem Lett 21: 6258-63 (2011)
Pfizer
Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors.EBI
Bioorg Med Chem Lett 21: 6264-9 (2011)
Hoffmann-La Roche
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.EBI
Bioorg Med Chem Lett 21: 6322-7 (2011)
National Human Genome Research Institute
Indolin-2-one p38a inhibitors III: bioisosteric amide replacement.EBI
Bioorg Med Chem Lett 21: 6253-7 (2011)
RhôNe-Poulenc Rorer
Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis.EBI
Bioorg Med Chem Lett 21: 6608-12 (2011)
Amira Pharmaceuticals
Discovery of aminobenzyloxyarylamides as¿ opioid receptor selective antagonists: application to preclinical development of a¿ opioid receptor antagonist receptor occupancy tracer.EBI
J Med Chem 54: 8000-12 (2011)
Eli Lilly
Synthesis and biochemical evaluation ofd(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.EBI
J Med Chem 54: 7663-77 (2011)
Universit£
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).EBI
Bioorg Med Chem Lett 21: 6591-5 (2011)
Pfizer
Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region.EBI
Bioorg Med Chem Lett 21: 6348-52 (2011)
Pfizer
Discovery of pyrazoles as novel FPR1 antagonists.EBI
Bioorg Med Chem Lett 21: 6456-60 (2011)
Astrazeneca
Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).EBI
Bioorg Med Chem 19: 6409-18 (2011)
Martin-Luther-University Halle-Wittenberg
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4.EBI
Bioorg Med Chem 19: 6356-74 (2011)
Celgene
Lysine demethylases inhibitors.EBI
J Med Chem 54: 8236-50 (2011)
Kyoto Prefectural University of Medicine
Optimization of propafenone analogues as antimalarial leads.EBI
J Med Chem 54: 7477-85 (2011)
St. Jude Children'S Research Hospital
Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.EBI
J Med Chem 54: 7503-22 (2011)
University of Canterbury
Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.EBI
J Med Chem 54: 7385-96 (2011)
Corning
Triazine-based vanilloid 1 receptor open channel blockers: design, synthesis, evaluation, and SAR analysis.EBI
J Med Chem 54: 7441-52 (2011)
Institut De Qu£Mica Avan£Ada De Catalunya
Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.EBI
Bioorg Med Chem Lett 21: 6366-9 (2011)
Novartis Institutes of Biomedical Research
Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.EBI
Bioorg Med Chem Lett 21: 6461-4 (2011)
Glaxosmithkline Research & Development
Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) inhibitors for the treatment of osteoporosis.EBI
Eur J Med Chem 47: 1-17 (2012)
Saarland University
Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Ka inhibitors.EBI
Eur J Med Chem 46: 5540-8 (2011)
Zhejiang University
Design, structure-activity relationship, and highly efficient asymmetric synthesis of 3-phenyl-4-benzylaminopiperidine derivatives as novel neurokinin-1 receptor antagonists.EBI
Bioorg Med Chem 19: 6430-46 (2011)
Takeda Pharmaceutical
Identification of novel plasmin inhibitors possessing nitrile moiety as warhead.EBI
Bioorg Med Chem Lett 21: 6305-9 (2011)
Hiroshima International University
Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.EBI
Bioorg Med Chem Lett 21: 6310-3 (2011)
Kaken Pharmaceutical
Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity.EBI
Bioorg Med Chem Lett 21: 6362-5 (2011)
Cephalon
Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors.EBI
Bioorg Med Chem Lett 21: 6314-8 (2011)
Takeda Pharmaceutical
Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.EBI
Bioorg Med Chem Lett 21: 6274-80 (2011)
University of Regensburg
Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.EBI
Bioorg Med Chem Lett 21: 6288-92 (2011)
Astrazeneca R&D Charnwood
Steroidal C-21 mercapto derivatives as dissociated steroids: discovery of an inhaled dissociated steroid.EBI
Bioorg Med Chem Lett 21: 6343-7 (2011)
Merck Research Laboratories
Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents.EBI
Eur J Med Chem 46: 5416-34 (2011)
Universit£
Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potenta4ß2- anda6ß2-nicotinic acetylcholine receptor partial agonist.EBI
J Med Chem 54: 7588-601 (2011)
Universit£
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders.EBI
J Med Chem 54: 7334-49 (2011)
Merck
A sucrose-derived scaffold for multimerization of bioactive peptides.EBI
Bioorg Med Chem 19: 6474-82 (2011)
The University of Arizona
Aminomethyltetrazoles as potential inhibitors of the¿-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.EBI
Bioorg Med Chem 19: 6492-504 (2011)
Ludwig-Maximilians-University Munich
Homo- and hetero-dimers of inactive organophosphorous group binding at dual sites of AChE.EBI
Bioorg Med Chem Lett 21: 6404-8 (2011)
Chinese Academy of Agricultural Sciences
Design and synthesis of a library of chemokine antagonists.EBI
Bioorg Med Chem Lett 21: 6249-52 (2011)
Novartis Institutes of Biomedical Research
Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.EBI
J Nat Prod 74: 2081-8 (2011)
Guangzhou University of Chinese Medicine
Structure-based design of dipeptide derivatives for the human neutral endopeptidase.EBI
Bioorg Med Chem 19: 5935-47 (2011)
Kao
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.EBI
Bioorg Med Chem Lett 21: 6440-5 (2011)
Novartis Institutes For Biomedical Research
Asymmetric synthesis and biological evaluation of N-cyclohexyl-4-[1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl]piperazine-1-carboxamide as hCB1 receptor antagonists.EBI
Eur J Med Chem 46: 5310-6 (2011)
Shanghai Institute of Materia Medica
Recent progress in synthesis and bioactivity studies of indolizines.EBI
Eur J Med Chem 46: 5237-57 (2011)
University of Botswana
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.EBI
J Med Chem 54: 7066-83 (2011)
Novartis Institute For Biomedical Research
Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.EBI
J Med Chem 54: 7268-79 (2011)
Industrial Research
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists.EBI
J Med Chem 54: 7693-704 (2011)
Pfizer
Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs).EBI
Bioorg Med Chem 19: 5924-34 (2011)
University of Antwerp
Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF¿?) receptor antagonists.EBI
Bioorg Med Chem 19: 5955-66 (2011)
Minase Research Institute
Synthesis, pharmacophore modeling and in vitro activity of 10,11-dihydrodibenzo[b,f]oxepine-4-carboxamide derivatives as novel and potent antagonists of the prostaglandin EP4 receptor.EBI
Bioorg Med Chem Lett 21: 6336-40 (2011)
Rottapharm Madaus
Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.EBI
Bioorg Med Chem Lett 21: 6389-92 (2011)
Shanghai Jiao Tong University
Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071.EBI
Bioorg Med Chem Lett 21: 6451-5 (2011)
Vanderbilt University Medical Center
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).EBI
J Med Chem 54: 7602-20 (2011)
Pfizer
Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.EBI
J Med Chem 54: 7375-84 (2011)
Universit£
Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17▀-HSD1 Inhibitor 16▀-(m-Carbamoylbenzyl)estradiol.EBI
ACS Med Chem Lett 2: 678-681 (2011)
TBA
NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor.EBI
ACS Med Chem Lett 2: 656-661 (2011)
TBA
Ligand discovery from a dopamine D3 receptor homology model and crystal structure.BDB
Nat Chem Biol 7: 769-78 (2011)
University of California San Francisco
The discovery of long-acting saligeninß2 adrenergic receptor agonists incorporating a urea group.EBI
Bioorg Med Chem 19: 6026-32 (2011)
Glaxosmithkline
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.EBI
Bioorg Med Chem 19: 6135-42 (2011)
University of Arizona
Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.EBI
Bioorg Med Chem 19: 5999-6005 (2011)
University of Waterloo
Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.EBI
Bioorg Med Chem 19: 5948-54 (2011)
Nanjing University
Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.EBI
Bioorg Med Chem Lett 21: 6485-90 (2011)
Johnson & Johnson Pharmaceutical Research & Development
Fragment based discovery of a novel and selective PI3 kinase inhibitor.EBI
Bioorg Med Chem Lett 21: 6586-90 (2011)
Pfizer
Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI
Eur J Med Chem 46: 5680-7 (2011)
Fudan University
Selectivity of 3'-O-methylponkoranol for inhibition of N- and C-terminal maltase glucoamylase and sucrase isomaltase, potential therapeutics for digestive disorders or their sequelae.EBI
Bioorg Med Chem Lett 21: 6491-4 (2011)
Simon Fraser University
5-(2'-Pyridyl)-2-aminothiazoles: alkyl amino sulfonamides and sulfamides as potent NPY(5) antagonists.EBI
Bioorg Med Chem Lett 21: 6500-4 (2011)
Lundbeck Research Usa
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.EBI
Eur J Med Chem 46: 5435-42 (2011)
University of Bologna
Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group.EBI
Eur J Med Chem 46: 5387-97 (2011)
Shandong University
Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.EBI
Bioorg Med Chem Lett 21: 6603-7 (2011)
Chungnam National University
Aminothiazoles as¿-secretase modulators.EBI
Bioorg Med Chem Lett 21: 6554-8 (2011)
F. Hoffmann-La Roche
Conversion of systemically-distributed triazole-based stearoyl-CoA desaturase (SCD) uHTS hits into liver-targeted SCD inhibitors.EBI
Bioorg Med Chem Lett 21: 6505-9 (2011)
Merck Frosst Centre For Therapeutic Research
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 6409-13 (2011)
Takeda Pharmaceutical
Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B).EBI
J Med Chem 54: 7023-9 (2011)
Karolinska Institutet
Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.EBI
J Med Chem 54: 7535-46 (2011)
Academy of Sciences of The Czech Republic
A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: synthesis, resolution, pharmacology, and crystal structure.EBI
J Med Chem 54: 7289-98 (2011)
University of Copenhagen
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.EBI
J Med Chem 54: 7127-37 (2011)
University of Santiago De Compostela
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.EBI
J Med Chem 54: 7350-62 (2011)
Merck Research Laboratories
Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.EBI
J Med Chem 54: 7408-16 (2011)
Neuraxon
HLE-inhibitory alkaloids with a polyketide skeleton from the marine-derived fungus Coniothyrium cereale.EBI
J Nat Prod 74: 2282-5 (2011)
University of Bonn
Synthesis and biological evaluation of phenstatin metabolites.EBI
Bioorg Med Chem 19: 6042-54 (2011)
University of Lille
Metronidazole acid acyl sulfonamide: a novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors.EBI
Bioorg Med Chem 19: 6069-76 (2011)
Nanjing University
Lead identification ofß-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90.EBI
Bioorg Med Chem 19: 6055-68 (2011)
Trinity College
Novel human mPGES-1 inhibitors identified through structure-based virtual screening.EBI
Bioorg Med Chem 19: 6077-86 (2011)
University of Kentucky
Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.EBI
Bioorg Med Chem 19: 6107-19 (2011)
Vu University Amsterdam
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist.EBI
Bioorg Med Chem Lett 21: 6596-602 (2011)
Pfizer
Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930.EBI
Bioorg Med Chem Lett 21: 6495-9 (2011)
St. John'S University
New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.EBI
Bioorg Med Chem Lett 21: 6567-72 (2011)
University of Strasburg
Tricyclic aminopyrimidine histamine H4 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 6577-81 (2011)
Johnson & Johnson Pharmaceutical Research & Development
Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.EBI
Bioorg Med Chem Lett 21: 6563-6 (2011)
Charles University In Prague
Discovery and development ofa7 nicotinic acetylcholine receptor modulators.EBI
J Med Chem 54: 7943-61 (2011)
Targacept
Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 6414-6 (2011)
Takeda Pharmaceutical
Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.EBI
Bioorg Med Chem Lett 21: 6042-8 (2011)
Johnson & Johnson Pharmaceutical Research and Development
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.EBI
J Med Chem 54: 7299-317 (2011)
Merck Serono
Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitors.EBI
J Med Chem 54: 7176-83 (2011)
Stevens Institute of Technology
6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.EBI
J Med Chem 54: 7055-65 (2011)
Ochanomizu University
Berkeleyones and related meroterpenes from a deep water acid mine waste fungus that inhibit the production of interleukin 1-ß from induced inflammasomes.EBI
J Nat Prod 74: 2273-7 (2011)
The University of Montana
Discovery of novel selective norepinephrine inhibitors: 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides (WYE-114152).EBI
J Med Chem 54: 6824-31 (2011)
Pfizer
Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.EBI
J Med Chem 54: 7165-75 (2011)
Universit£
Thermodynamic evaluation of ligand binding in the plant-like phosphoethanolamine methyltransferases of the parasitic nematode Haemonchus contortus.BDB
J Biol Chem 286: 38060-8 (2011)
Washington University
Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.EBI
Bioorg Med Chem 19: 6015-25 (2011)
Shandong University
Potent inhibition of bacterial neuraminidase activity by pterocarpans isolated from the roots of Lespedeza bicolor.EBI
Bioorg Med Chem Lett 21: 6100-3 (2011)
Gyeongsang National University
Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)pyrazoles as transforming growth factor-ß type 1 receptor kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 6049-53 (2011)
Ewha Womans University
Does the combination of optimal substitutions at the C²-, N¿?¿- and N¿?¿-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A3 adenosine receptors?EBI
Bioorg Med Chem 19: 6120-34 (2011)
National University of Singapore
Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core.EBI
Bioorg Med Chem Lett 21: 6122-5 (2011)
Pfizer
CNS and antimalarial activity of synthetic meridianin and psammopemmin analogs.EBI
Bioorg Med Chem 19: 5756-62 (2011)
University of South Florida
Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders.EBI
Bioorg Med Chem Lett 21: 6031-5 (2011)
Astrazeneca
Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.EBI
Bioorg Med Chem 19: 5852-60 (2011)
Universit£
Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.EBI
Bioorg Med Chem 19: 5813-32 (2011)
Green Cross
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 6126-30 (2011)
Cephalon
Design, synthesis, and biological evaluation of chromone-based p38 MAP kinase inhibitors.EBI
J Med Chem 54: 7427-31 (2011)
University of Gothenburg
Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.EBI
J Med Chem 54: 7648-62 (2011)
Technische Universit£T M£Nchen
Deconstruction of thea4ß2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.EBI
J Med Chem 54: 7259-67 (2011)
Virginia Commonwealth University
Discovery of isoxazole analogues of sazetidine-A as selectivea4ß2-nicotinic acetylcholine receptor partial agonists for the treatment of depression.EBI
J Med Chem 54: 7280-8 (2011)
University of Illinois At Chicago
Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria.EBI
Bioorg Med Chem 19: 5886-95 (2011)
University of Utah
1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents.EBI
Bioorg Med Chem 19: 5794-802 (2011)
Volgograd State Medical University
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.EBI
Bioorg Med Chem 19: 5803-12 (2011)
Kyoto Prefectural University
Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.EBI
Bioorg Med Chem 19: 5833-51 (2011)
Chdi Management
Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.EBI
Bioorg Med Chem Lett 21: 6094-9 (2011)
University of Michigan
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.EBI
Bioorg Med Chem Lett 21: 6188-94 (2011)
Glaxosmithkline
Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7.EBI
Bioorg Med Chem Lett 21: 6112-5 (2011)
Universidade Federal Do Tri£Ngulo Mineiro
Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1a-hydroxy-19-norvitamin D analogues with shortened alkyl side chains.EBI
J Med Chem 54: 6832-42 (2011)
University of Warsaw
Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.EBI
J Med Chem 54: 7232-46 (2011)
Amgen
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).EBI
J Nat Prod 74: 2019-22 (2011)
Universita` Del Piemonte Orientale
Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.EBI
Eur J Med Chem 46: 5154-61 (2011)
The University of Mississippi
Monoamine oxidase inhibition by selected anilide derivatives.EBI
Eur J Med Chem 46: 5162-74 (2011)
North-West University
SAR and LC/MS studies ofß-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process.EBI
J Med Chem 54: 6812-23 (2011)
Universit£
P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant viruses.EBI
J Med Chem 54: 7094-104 (2011)
Abbott Laboratories
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791EBI
J Med Chem 54: 7318-33 (2011)
Bristol-Myers Squibb
Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent.EBI
J Med Chem 54: 6734-50 (2011)
Astrazeneca
Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.EBI
J Med Chem 54: 6456-68 (2011)
University of Eastern Finland
Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.EBI
Bioorg Med Chem Lett 21: 6074-80 (2011)
University of Alberta
Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene.EBI
Bioorg Med Chem Lett 21: 6154-60 (2011)
Glaxosmithkline
Modeling the molecular basis fora4ß1 integrin antagonism.EBI
Bioorg Med Chem 19: 5903-11 (2011)
Ian Wark Laboratories
Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.EBI
Bioorg Med Chem Lett 21: 6116-21 (2011)
Nanjing University
Acylglycinamides as inhibitors of glycine transporter type 1.EBI
Bioorg Med Chem Lett 21: 6176-9 (2011)
Glaxosmithkline
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.EBI
Bioorg Med Chem Lett 21: 6139-42 (2011)
Wayne State University
Inhibition of xc¿?¿ transporter-mediated cystine uptake by sulfasalazine analogs.EBI
Bioorg Med Chem Lett 21: 6184-7 (2011)
Johns Hopkins University
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet).EBI
Bioorg Med Chem Lett 21: 6198-202 (2011)
Kitasato University
Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands.EBI
Bioorg Med Chem Lett 21: 6104-7 (2011)
National Institute of Health Sciences
Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profiles.EBI
Bioorg Med Chem Lett 21: 6108-11 (2011)
Pfizer
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism.EBI
Eur J Med Chem 46: 5218-24 (2011)
Universit£
Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease.EBI
J Med Chem 54: 7797-814 (2011)
Pfizer
Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives.EBI
J Med Chem 54: 7422-6 (2011)
Martin-Luther-Universit£T Halle-Wittenberg
Design and synthesis of new prostaglandin D2 receptor antagonists.EBI
Bioorg Med Chem 19: 5361-71 (2011)
Minase Research Institute
Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: comparison of binding to non-phosphorylated and phosphorylated VEGFR2.EBI
Bioorg Med Chem 19: 5342-51 (2011)
Takeda Pharmaceutical
Sulfonamides as selective oestrogen receptorß agonists.EBI
Bioorg Med Chem Lett 21: 5680-3 (2011)
Pfizer
Discovery of a highly potent series of TLR7 agonists.EBI
Bioorg Med Chem Lett 21: 5939-43 (2011)
Pfizer
Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent ?-secretase inhibitors.EBI
Bioorg Med Chem Lett 21: 5791-4 (2011)
Elan Pharmaceuticals
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability.EBI
Bioorg Med Chem Lett 21: 5684-7 (2011)
Pfizer
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical properties and biological activity.EBI
Eur J Med Chem 46: 5086-98 (2011)
Abbott Healthcare Products
Synthesis and biological evaluation of novel analogues of the pan class I phosphatidylinositol 3-kinase (PI3K) inhibitor 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474).EBI
J Med Chem 54: 7105-26 (2011)
University of Auckland
The development of N-a-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-a-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.EBI
J Med Chem 54: 6919-35 (2011)
The Scripps Research Institute
Small molecule receptor protein tyrosine phosphatase¿ (RPTP¿) ligands that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loop.EBI
J Med Chem 54: 6548-62 (2011)
Bristol-Myers Squibb Research and Development
2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.BDB
J Biol Chem 286: 37578-89 (2011)
Astrazeneca R&D
Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D ╬▓-lactamase from Acinetobacter baumannii.BDB
J Biol Chem 286: 37292-303 (2011)
York University
Chemical modifications of resveratrol for improved protein kinase C alpha activity.EBI
Bioorg Med Chem 19: 5321-33 (2011)
University of Houston
Synthesis and acrosin inhibitory activities of substituted ethyl 5-(4-aminophenyl)-1H-pyrazole-3-carboxylate derivatives.EBI
Bioorg Med Chem Lett 21: 5822-5 (2011)
Second Military Medical University
Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma.EBI
Bioorg Med Chem Lett 21: 5826-30 (2011)
Pfizer
Conformationally constrained analogs of BAY 59-3074 as novel cannabinoid receptor ligands.EBI
Bioorg Med Chem Lett 21: 5999-6002 (2011)
Northeastern University
Discovery of inhibitors of plasminogen activator inhibitor-1: structure-activity study of 5-nitro-2-phenoxybenzoic acid derivatives.EBI
Bioorg Med Chem Lett 21: 5701-6 (2011)
Zydus Research Centre
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.EBI
Eur J Med Chem 46: 4808-19 (2011)
Abbott Healthcare Products
Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits b-glycinamide ribonucleotide formyltransferase.EBI
J Med Chem 54: 7150-64 (2011)
Duquesne University
Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.EBI
Bioorg Med Chem 19: 5628-38 (2011)
Astellas Pharma
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.EBI
Bioorg Med Chem Lett 21: 5854-8 (2011)
Drexel University
Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.EBI
Bioorg Med Chem Lett 21: 5778-83 (2011)
Chugai Pharmaceutical
Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity.EBI
Bioorg Med Chem Lett 21: 5711-4 (2011)
Rti International
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors.EBI
Bioorg Med Chem Lett 21: 5735-8 (2011)
Guru Ghasidas University
Mitochondrial respiration inhibitors suppress protein translation and hypoxic signaling via the hyperphosphorylation and inactivation of translation initiation factor eIF2? and elongation factor eEF2.EBI
J Nat Prod 74: 1894-901 (2011)
University of Mississippi
Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).EBI
J Med Chem 54: 6956-68 (2011)
University of Cape Town
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.EBI
ACS Med Chem Lett 2: 39-42 (2011)
Broad Institute of Harvard and Mit
5a-Carba-ß-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.EBI
Bioorg Med Chem 19: 5334-41 (2011)
Chugai Pharmaceutical
SAR studies of acidic dual¿-secretase/PPAR¿ modulators.EBI
Bioorg Med Chem 19: 5372-82 (2011)
Goethe-University Frankfurt
Synthesis and structure-activity relationship of 4-quinolone-3-carboxylic acid based inhibitors of glycogen synthase kinase-3ß.EBI
Bioorg Med Chem Lett 21: 5948-51 (2011)
Activx Biosciences
Potent and novel 11ß-HSD1 inhibitors identified from shape and docking based virtual screening.EBI
Bioorg Med Chem Lett 21: 5739-44 (2011)
Shanghai Pharmaceutical Holding
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aß-aggregation inhibitors: Synthesis and biological evaluation.EBI
Bioorg Med Chem Lett 21: 5881-7 (2011)
University of Waterloo
Improved synthesis and biological evaluation of chelator-modifieda-MSH analogs prepared by copper-free click chemistry.EBI
Bioorg Med Chem Lett 21: 5757-61 (2011)
The University of Iowa
Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.EBI
Bioorg Med Chem Lett 21: 5924-7 (2011)
Boehringer Ingelheim Pharma
Identification of novel BRAF kinase inhibitors with structure-based virtual screening.EBI
Bioorg Med Chem Lett 21: 5753-6 (2011)
Sejong University
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.EBI
Eur J Med Chem 46: 5039-45 (2011)
Shandong University
Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.EBI
Bioorg Med Chem 19: 5698-707 (2011)
The University of Texas
Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent.EBI
Eur J Med Chem 46: 5206-11 (2011)
Central Drug Research Institute (Csir)
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.EBI
Eur J Med Chem 46: 4846-52 (2011)
Sapienza University of Rome
Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors.EBI
Bioorg Med Chem Lett 21: 5692-6 (2011)
Merck Frosst Centre For Therapeutic Research
Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazines¿? receptor ligands.EBI
Bioorg Med Chem Lett 21: 5707-10 (2011)
The University of Sydney
Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.EBI
Eur J Med Chem 46: 4946-56 (2011)
RhôNe-Poulenc Rorer
Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-inducedß-amyloid aggregation inhibitors.EBI
Eur J Med Chem 46: 4970-9 (2011)
Guangxi Normal University
Inhalation by design: novel tertiary amine muscarinic M3 receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.EBI
J Med Chem 54: 6888-904 (2011)
Pfizer
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for humanß-adrenoceptors.EBI
J Med Chem 54: 6874-87 (2011)
University of Nottingham
Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-D-Ala-Phe-Gly-NH2 using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold.EBI
J Med Chem 54: 6538-47 (2011)
Vrije Universiteit Brussel
Actinopolysporins A-C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600.EBI
J Nat Prod 74: 1990-5 (2011)
Yunnan University
Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.BDB
Biochemistry 50: 8478-88 (2011)
Venetian Institute of Molecular Medicine
Substrate specificity of Sphingobium chlorophenolicum 2,6-dichlorohydroquinone 1,2-dioxygenase.BDB
Biochemistry 50: 8899-913 (2011)
Whitman College
Novel macrocyclic C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.EBI
Bioorg Med Chem 19: 5468-79 (2011)
Green Cross
Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.EBI
Bioorg Med Chem Lett 21: 5812-7 (2011)
Piramal Life Sciences
Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils.EBI
Eur J Med Chem 46: 5021-33 (2011)
Gazi University
Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB(2) Receptor Inverse Agonists.BDB
Chem Biol 18: 1053-64 (2011)
University of Bern
Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus.BDB
Chem Biol 18: 1032-41 (2011)
The University of Chicago
Selective water-soluble gelatinase inhibitor prodrugs.EBI
J Med Chem 54: 6676-90 (2011)
University of Notre Dame
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT6R) antagonists with unique structural features.EBI
J Med Chem 54: 7030-54 (2011)
Abbott Healthcare Products
Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine.EBI
J Med Chem 54: 6531-7 (2011)
University of Bath
2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): a potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A.EBI
Bioorg Med Chem 19: 5490-9 (2011)
Dainippon Sumitomo Pharma
6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists.EBI
Bioorg Med Chem 19: 5432-45 (2011)
Minase Research Institute
Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents.EBI
Eur J Med Chem 46: 4992-9 (2011)
Wroclaw Medical University
4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKC¿.EBI
J Med Chem 54: 6714-23 (2011)
Saarland University
Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-ß2-agonist for the treatment of chronic obstructive pulmonary disease.EBI
J Med Chem 54: 6998-7002 (2011)
Pfizer
Cyclopentane-1,3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonists.EBI
J Med Chem 54: 6969-83 (2011)
University of Pennsylvania
Assessment of dopamine D¿? receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393.EBI
Bioorg Med Chem 19: 5420-31 (2011)
Purdue University
Synthesis and glycosidase inhibitory profiles of functionalised morpholines and oxazepanes.EBI
Bioorg Med Chem 19: 5679-92 (2011)
University of Reading
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.EBI
Bioorg Med Chem 19: 5569-76 (2011)
Indo-Soviet Friendship College of Pharmacy
Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 5952-6 (2011)
Pfizer
Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.EBI
J Med Chem 54: 6597-611 (2011)
University of Manchester
Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT7 receptor antagonist activity.EBI
J Med Chem 54: 6657-69 (2011)
Egis Pharmaceuticals
2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity.EBI
J Med Chem 54: 6328-41 (2011)
Cephalon
Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with highs1 receptor affinity.EBI
J Med Chem 54: 6704-13 (2011)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition Element.EBI
ACS Med Chem Lett 2: 626-631 (2011)
TBA
Discovery, synthesis, and structure-activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonists.EBI
Bioorg Med Chem 19: 5539-52 (2011)
Takeda Pharmaceutical
De novo design, synthesis and biological evaluation of 1,4-dihydroquinolin-4-ones and 1,2,3,4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors.EBI
Bioorg Med Chem 19: 5612-27 (2011)
China Pharmaceutical University
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells.EBI
Bioorg Med Chem Lett 21: 5928-33 (2011)
University of Siena
Overcoming human P-glycoprotein-dependent multidrug resistance with novel dihydro-ß-agarofuran sesquiterpenes.EBI
Eur J Med Chem 46: 4915-23 (2011)
Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
Inhibition of LuxS by S-ribosylhomocysteine analogues containing a [4-aza]ribose ring.EBI
Bioorg Med Chem 19: 5507-19 (2011)
Florida International University
Development and characterization of improvedß-lactone-based anti-virulence drugs targeting ClpP.EBI
Bioorg Med Chem 20: 583-91 (2012)
Technische Universit£T M£Nchen
Synthesis and characterization of tritylthioethanamine derivatives with potent KSP inhibitory activity.EBI
Bioorg Med Chem 19: 5446-53 (2011)
New Mexico State University
Substituted lactam and cyclic azahemiacetals modulate Pseudomonas aeruginosa quorum sensing.EBI
Bioorg Med Chem 19: 5500-6 (2011)
Florida International University
Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.EBI
Bioorg Med Chem Lett 21: 5849-53 (2011)
N30 Pharmaceuticals
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells.EBI
Bioorg Med Chem Lett 21: 5859-62 (2011)
University of Montana
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors.EBI
Bioorg Med Chem Lett 21: 5870-5 (2011)
Merck Research Laboratories
Ursolic acid is a PPAR-a agonist that regulates hepatic lipid metabolism.EBI
Bioorg Med Chem Lett 21: 5876-80 (2011)
Korea University
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties.EBI
J Med Chem 54: 6691-703 (2011)
University of Southern Denmark
Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.EBI
Bioorg Med Chem Lett 21: 5892-6 (2011)
University of Alberta
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P¿? agonists.EBI
Bioorg Med Chem Lett 21: 6013-8 (2011)
Arena Pharmaceuticals
Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors.EBI
Bioorg Med Chem Lett 21: 5992-4 (2011)
The Walter and Eliza Hall Institute of Medical Research
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.EBI
Bioorg Med Chem Lett 21: 5971-4 (2011)
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Effects of some drugs on human cord blood erythrocyte carbonic anhydrases I and II: an in vitro study.BDB
J Enzyme Inhib Med Chem 27: 641-5 (2012)
Erzincan University
Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.EBI
J Med Chem 54: 6905-18 (2011)
Griffith University
Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.EBI
J Med Chem 54: 6514-30 (2011)
University of Dundee
Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis.EBI
J Med Chem 54: 7193-205 (2011)
Indiana University School of Medicine
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.EBI
J Med Chem 54: 6761-70 (2011)
University of Oxford
Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.EBI
Eur J Med Chem 46: 4648-56 (2011)
University of Ljubljana
Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.BDB
Chem Biol Drug Des 78: 869-75 (2011)
Yeditepe University
Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.BDB
J Enzyme Inhib Med Chem 27: 509-14 (2012)
Dumlupinar University
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.EBI
J Med Chem 54: 6197-205 (2011)
University of British Columbia
Anti-inflammatory endiandric acid analogues from the roots of Beilschmiedia tsangii.EBI
J Nat Prod 74: 1875-80 (2011)
Kaohsiung Medical University
A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13.EBI
Bioorg Med Chem 19: 5716-33 (2011)
Universit£
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 5957-60 (2011)
Pfizer
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.EBI
Bioorg Med Chem Lett 21: 5910-5 (2011)
Korea Institute of Science and Technology
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.EBI
Bioorg Med Chem Lett 21: 5964-70 (2011)
Chinese Academy of Medical Sciences
Inhibition of COX-1 activity and COX-2 expression by 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its semi-synthetic derivatives.EBI
Bioorg Med Chem Lett 21: 5995-8 (2011)
Universit£
Agonists for the Chemokine Receptor CXCR4.EBI
ACS Med Chem Lett 2: 597-602 (2011)
TBA
Mechanistic analysis of trehalose synthase from Mycobacterium smegmatis.BDB
J Biol Chem 286: 35601-9 (2011)
University of British Columbia
The structure-activity relationship of urea derivatives as anti-tuberculosis agents.EBI
Bioorg Med Chem 19: 5585-95 (2011)
St. Jude Children'S Research Hospital
Cracking the molecular weight barrier: fragment screening of an aminotransferase using an NMR-based functional assay.EBI
Bioorg Med Chem Lett 21: 5248-50 (2011)
Abbott Laboratories
Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.EBI
Bioorg Med Chem Lett 21: 5149-54 (2011)
Institute of Technology and Science-Pilani
Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.EBI
Bioorg Med Chem Lett 21: 5480-6 (2011)
Deutschland
Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.EBI
Bioorg Med Chem Lett 21: 5206-9 (2011)
Amgen
Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.EBI
Bioorg Med Chem Lett 21: 5487-92 (2011)
Sanofi-Aventis Deutschland
DNA site-specific N3-adenine methylation targeted to estrogen receptor-positive cells.EBI
Bioorg Med Chem 19: 5093-102 (2011)
University of North Carolina At Wilmington
Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).EBI
J Med Chem 54: 6803-11 (2011)
Cardiff University
Discovery of a brain-penetrant S1P3-sparing direct agonist of the S1P¿? and S1P5 receptors efficacious at low oral dose.EBI
J Med Chem 54: 6724-33 (2011)
Glaxosmithkline
The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach.EBI
Bioorg Med Chem Lett 21: 5224-9 (2011)
Astrazeneca
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.EBI
Bioorg Med Chem Lett 21: 5164-70 (2011)
Pfizer
Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.EBI
Eur J Med Chem 46: 4489-505 (2011)
Universit£
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.EBI
Bioorg Med Chem Lett 21: 5562-7 (2011)
Glaxosmithkline
Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.EBI
Bioorg Med Chem Lett 21: 5528-32 (2011)
Emory University School of Medicine
Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.EBI
Bioorg Med Chem Lett 21: 5171-6 (2011)
Trius Therapeutics, San Diego, Ca 92121, United States.
Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.EBI
Bioorg Med Chem Lett 21: 5230-3 (2011)
Pfizer
Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1a inhibitors.EBI
Bioorg Med Chem Lett 21: 5239-43 (2011)
National Human Genome Research Institute
Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-a converting enzyme (TACE/ADAM-17).BDB
J Enzyme Inhib Med Chem 27: 533-40 (2012)
China Pharmaceutical University
Sesterterpenes from the tropical sponge Coscinoderma sp.EBI
J Nat Prod 74: 1805-11 (2011)
Seoul National University
Discovery of a novel series of selective HCN1 blockers.EBI
Bioorg Med Chem Lett 21: 5197-201 (2011)
Johnson & Johnson Pharmaceutical Research & Development
Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2.EBI
Bioorg Med Chem Lett 21: 5191-6 (2011)
Amgen
Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.EBI
Bioorg Med Chem Lett 21: 5602-4 (2011)
Korea Research Institute of Bioscience and Biotechnology
Amine-constrained pyridazinone histamine H3 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 5543-6 (2011)
Cephalon
Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.EBI
Bioorg Med Chem Lett 21: 5403-7 (2011)
Uppsala University
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-a.EBI
Bioorg Med Chem Lett 21: 5423-7 (2011)
University of Ferrara
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 5234-8 (2011)
Neuraxon
Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein.EBI
Eur J Med Chem 46: 4506-20 (2011)
Universit£
9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors.EBI
J Med Chem 54: 6286-94 (2011)
Chugai Pharmaceutical
Identification and characterization of a novel integrin-linked kinase inhibitor.EBI
J Med Chem 54: 6364-74 (2011)
The Ohio State University
Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.EBI
J Med Chem 54: 6305-18 (2011)
Green Cross
Halogen-substituted (C-ß-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase.EBI
Bioorg Med Chem 19: 5125-36 (2011)
National Hellenic Research Foundation
Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors.EBI
Bioorg Med Chem 19: 5255-9 (2011)
Columbia University Medical Center
Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against humana- and bacterial/fungalß-carbonic anhydrases.EBI
Bioorg Med Chem Lett 21: 5210-3 (2011)
Ecole Nationale Sup£Rieure De Chimie De Montpellier
The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.EBI
Bioorg Med Chem Lett 21: 5159-63 (2011)
Virginia Commonwealth University
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.EBI
Eur J Med Chem 46: 4466-73 (2011)
Universit£
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.EBI
Eur J Med Chem 46: 4403-10 (2011)
Medical University of Gdansk
Discovery, synthesis, and biological evaluation of novel SMN protein modulators.EBI
J Med Chem 54: 6215-33 (2011)
National Human Genome Research Institute
Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.EBI
Eur J Med Chem 46: 4702-8 (2011)
Nanjing University
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1.EBI
Eur J Med Chem 46: 4474-88 (2011)
Medical University of Warsaw
Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.BDB
J Enzyme Inhib Med Chem 27: 467-75 (2012)
Artvin Coruh University
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.EBI
J Med Chem 54: 6206-14 (2011)
Sanford-Burnham Medical Research Institute
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.EBI
Bioorg Med Chem Lett 21: 5521-7 (2011)
Elan Pharmaceuticals
1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 5301-4 (2011)
Neuraxon
Indolin-2-one p38a inhibitors II: Lead optimisation.EBI
Bioorg Med Chem Lett 21: 5270-3 (2011)
RhôNe-Poulenc Rorer
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).EBI
J Med Chem 54: 6342-63 (2011)
Pfizer
Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.EBI
J Med Chem 54: 6399-403 (2011)
Northwestern University
3-benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis.EBI
Bioorg Med Chem 19: 5175-82 (2011)
Takeda Pharmaceutical
A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase.EBI
Bioorg Med Chem Lett 21: 5255-8 (2011)
Universit£
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.EBI
Bioorg Med Chem Lett 21: 4951-5 (2011)
University of Washington
Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteases.EBI
Bioorg Med Chem Lett 21: 5305-9 (2011)
The Johns Hopkins University
Synthesis and biological evaluation of glycogen synthase kinase 3 (GSK-3) inhibitors: an fast and atom efficient access to 1-aryl-3-benzylureas.EBI
Bioorg Med Chem Lett 21: 5610-5 (2011)
Technische Universit£T Darmstadt
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors.EBI
Bioorg Med Chem Lett 21: 5342-6 (2011)
Ambit Biosciences
N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and function.EBI
J Med Chem 54: 5981-7 (2011)
Salk Institute
Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula.EBI
J Nat Prod 74: 1686-91 (2011)
National Cancer Institute-Frederick
Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.EBI
Bioorg Med Chem 19: 5238-46 (2011)
Kyoto Pharmaceutical University
Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors.EBI
Bioorg Med Chem Lett 21: 5274-82 (2011)
Merck Research Laboratories
Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication.EBI
Eur J Med Chem 46: 4281-8 (2011)
Universit£S Aix-Marseille I Et Ii
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.EBI
Eur J Med Chem 46: 4419-29 (2011)
University of Regensburg
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor.EBI
Bioorg Med Chem Lett 21: 5552-6 (2011)
Johnson & Johnson Pharmaceutical Research & Development
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.EBI
Bioorg Med Chem Lett 21: 5378-83 (2011)
Bioprojet-Biotech
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 5296-300 (2011)
Ambit Biosciences
N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.EBI
Bioorg Med Chem Lett 21: 5283-8 (2011)
Merck Research Laboratories
Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.EBI
Bioorg Med Chem 19: 5207-24 (2011)
Daiichi Sankyo
Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for thea1-adrenoceptors.EBI
Bioorg Med Chem 19: 5260-76 (2011)
Universit£
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.EBI
Bioorg Med Chem 19: 5190-8 (2011)
Shandong University
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships.EBI
Bioorg Med Chem Lett 21: 5533-7 (2011)
Arraybiopharma
Strategies to lower the Pgp efflux liability in a series of potent indole azetidine MCHR1 antagonists.EBI
Bioorg Med Chem Lett 21: 5310-4 (2011)
Lundbeck Research Usa
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.EBI
Bioorg Med Chem Lett 21: 5374-7 (2011)
Nanjing University
High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.BDB
Chem Biol 18: 868-79 (2011)
Harvard Medical School
Design of HIV-1 protease inhibitors with C3-substituted hexahydrocyclopentafuranyl urethanes as P2-ligands: synthesis, biological evaluation, and protein-ligand X-ray crystal structure.EBI
J Med Chem 54: 5890-901 (2011)
Purdue University
Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro.EBI
J Nat Prod 74: 1779-86 (2011)
University of Innsbruck
Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.EBI
Bioorg Med Chem 19: 4710-20 (2011)
Washington University
Thiolactone modulators of quorum sensing revealed through library design and screening.EBI
Bioorg Med Chem 19: 4820-8 (2011)
University of Wisconsin-Madison
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPAR¿ partial agonist.EBI
Bioorg Med Chem Lett 21: 5568-72 (2011)
Glaxosmithkline
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).EBI
Bioorg Med Chem Lett 21: 5633-7 (2011)
Biogen Idec
Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.EBI
Eur J Med Chem 46: 4336-43 (2011)
Institut F£R Molekulare Physiologie
Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.EBI
J Med Chem 54: 6028-39 (2011)
Novartis Institutes For Biomedical Research
SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1.EBI
J Med Chem 54: 6000-13 (2011)
Sanford-Burnham Medical Research Institute
Thermodynamic and biological evaluation of a thrombin binding aptamer modified with several unlocked nucleic acid (UNA) monomers and a 2'-C-piperazino-UNA monomer.EBI
Bioorg Med Chem 19: 4739-45 (2011)
University of Southern Denmark
Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors.EBI
Bioorg Med Chem Lett 21: 5398-402 (2011)
Batman University
Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors.EBI
Eur J Med Chem 46: 4311-23 (2011)
Universit£
Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.EBI
J Nat Prod 74: 2031-8 (2011)
University of Wisconsin-Milwaukee
A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.BDB
Chem Biol Drug Des 78: 667-78 (2011)
Sanford-Burnham Medical Research Institute
Synthesis and evaluation of novel carbon-11 labeled oxopurine analogues for positron emission tomography imaging of translocator protein (18 kDa) in peripheral organs.EBI
J Med Chem 54: 6040-9 (2011)
National Institute of Radiological Sciences
Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.EBI
Bioorg Med Chem 19: 4746-71 (2011)
Applied Science University
N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.EBI
Bioorg Med Chem Lett 21: 5289-92 (2011)
The University of Sydney
Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.EBI
Bioorg Med Chem Lett 21: 5428-31 (2011)
Huazhong University of Science and Technology
Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14ß-dihydroxy-4,5a-epoxy-6ß-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.EBI
Bioorg Med Chem Lett 21: 5625-9 (2011)
Virginia Commonwealth University
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain.EBI
Bioorg Med Chem Lett 21: 5605-9 (2011)
University of Toronto Mississauga
Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase type 1.EBI
J Med Chem 54: 6050-62 (2011)
Vitae Pharmaceuticals
Synthesis and in vitro evaluation of derivatives of theß¿?-adrenergic receptor antagonist HX-CH 44.EBI
Bioorg Med Chem Lett 21: 5506-9 (2011)
University of Toronto
SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor.EBI
Bioorg Med Chem Lett 21: 5470-4 (2011)
The Scripps Research Institute
Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.EBI
Bioorg Med Chem Lett 21: 5577-82 (2011)
Johnson & Johnson Pharmaceutical Research and Development
Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.EBI
Bioorg Med Chem Lett 21: 5384-8 (2011)
Bioprojet-Biotech
2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-ß1 and activin A signalling.EBI
Bioorg Med Chem Lett 21: 5642-5 (2011)
Monash University
Oxadiazole derivatives containing 1,4-benzodioxan as potential immunosuppressive agents against RAW264.7 cells.EBI
Bioorg Med Chem 19: 4895-902 (2011)
Nanjing University
Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.EBI
Bioorg Med Chem 19: 4772-81 (2011)
India Institute of Chemical Technology
LuxR dependent quorum sensing inhibition by N,N'-disubstituted imidazolium salts.EBI
Bioorg Med Chem 19: 4868-75 (2011)
Insa Lyon
Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors.EBI
Bioorg Med Chem Lett 21: 5616-9 (2011)
Purdue University
Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.EBI
Bioorg Med Chem Lett 21: 5493-7 (2011)
Cephalon
Monosubstituted¿-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors ofß-secretase (BACE).EBI
Bioorg Med Chem Lett 21: 6916-24 (2011)
Bristol-Myers Squibb
N-Heteroaryl glycinamides and glycinamines as potent NPY5 antagonists.EBI
Bioorg Med Chem Lett 21: 5573-6 (2011)
Lundbeck Research Usa
Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.EBI
Bioorg Med Chem Lett 21: 5460-4 (2011)
Vu University Amsterdam
Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.EBI
Bioorg Med Chem Lett 21: 5436-41 (2011)
Lundbeck Research Usa
Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors.EBI
Bioorg Med Chem Lett 21: 5432-5 (2011)
Astrazeneca R&D Boston
Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X7 receptor.EBI
Bioorg Med Chem Lett 21: 5475-9 (2011)
Pfizer
A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET.EBI
Bioorg Med Chem Lett 21: 5498-501 (2011)
Northeast Ohio Medical University
Synthesis and preliminary evaluation of a modified estradiol-core bearing a fused¿-lactone as non-estrogenic inhibitor of 17ß-hydroxysteroid dehydrogenase type 1.EBI
Bioorg Med Chem Lett 21: 5510-3 (2011)
Chuq - Research Center and Laval University
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI
J Med Chem 54: 6139-50 (2011)
University of North Carolina At Chapel Hill
Remarkable potential of thea-aminophosphonate/phosphinate structural motif in medicinal chemistry.EBI
J Med Chem 54: 5955-80 (2011)
Wroclaw University of Technology
A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.EBI
J Med Chem 54: 6063-84 (2011)
Universidad De Santiago De Compostela
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.EBI
Bioorg Med Chem 19: 4796-802 (2011)
National Taiwan University
Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.EBI
Bioorg Med Chem 19: 4829-40 (2011)
North-West University
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.EBI
Bioorg Med Chem 19: 4935-52 (2011)
Chinese Academy of Sciences
Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1.EBI
Bioorg Med Chem Lett 21: 4686-9 (2011)
Helmholtz Center Dresden-Rossendorf
Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase.EBI
Eur J Med Chem 46: 4330-5 (2011)
Universit£
The selective P-TEFb inhibitor CAN508 targets angiogenesis.EBI
Eur J Med Chem 46: 4289-94 (2011)
Palack£
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.EBI
J Med Chem 54: 6394-8 (2011)
University of Cagliari
Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging.EBI
J Med Chem 54: 5820-35 (2011)
Janssen-Cilag
Effects ofß-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro.EBI
Bioorg Med Chem 19: 4882-6 (2011)
Shanghai University of Traditional Chinese Medicine
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.EBI
Bioorg Med Chem 19: 4910-6 (2011)
Universit£
Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase.EBI
Bioorg Med Chem Lett 21: 4698-701 (2011)
Astrazeneca
Synthesis and structure-activity relationship of novel conformationally restricted analogues of serotonin as 5-HT6 receptor ligands.BDB
J Enzyme Inhib Med Chem 27: 443-50 (2012)
Suven Life Sciences
Biotransformation of dehydroepiandrosterone with Macrophomina phaseolina and ▀-glucuronidase inhibitory activity of transformed products.BDB
J Enzyme Inhib Med Chem 27: 348-55 (2012)
University of Karachi
Targeting the prostaglandin F2a receptor for preventing preterm labor with azapeptide tocolytics.EBI
J Med Chem 54: 6085-97 (2011)
Mcgill University Health Center Research Institute
Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.BDB
J Enzyme Inhib Med Chem 27: 302-10 (2012)
Shandong University
Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.EBI
Bioorg Med Chem 19: 5000-5 (2011)
University of Silesia
Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.EBI
Bioorg Med Chem Lett 21: 4762-7 (2011)
Johnson & Johnson Pharmaceutical Research and Development
Screening for GPCR Ligands Using Surface Plasmon Resonance.EBI
ACS Med Chem Lett 2: 549-554 (2011)
TBA
Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel.BDB
Nat Chem Biol 7: 595-601 (2011)
National Cancer Institute-Frederick
N-substituted homopiperazine barbiturates as gelatinase inhibitors.EBI
Bioorg Med Chem 19: 4985-99 (2011)
Trinity College
Shishicrellastatins, inhibitors of cathepsin B, from the marine sponge Crella (Yvesia) spinulata.EBI
Bioorg Med Chem 19: 6594-8 (2011)
The University of Tokyo
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3ß inhibitors.EBI
Bioorg Med Chem Lett 21: 4823-7 (2011)
Glaxosmithkline
Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.EBI
Bioorg Med Chem 19: 4953-70 (2011)
Takeda Pharmaceutical
Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.EBI
Bioorg Med Chem Lett 21: 4702-4 (2011)
Astrazeneca
Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.EBI
Bioorg Med Chem Lett 21: 4745-9 (2011)
Novartis Institutes For Biomedical Research
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).EBI
Bioorg Med Chem Lett 21: 4674-85 (2011)
The Scripps Research Institute
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.EBI
Eur J Med Chem 46: 4252-7 (2011)
Universit£
The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase.EBI
Bioorg Med Chem 19: 5012-22 (2011)
Nanjing University
NSAID-derived ?-secretase modulation requires an acidic moiety on the carbazole scaffold.EBI
Bioorg Med Chem 19: 4903-9 (2011)
Technische Universit£T Darmstadt
Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors.EBI
Bioorg Med Chem Lett 21: 4773-8 (2011)
Pfizer
Inhibition studies of theß-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.EBI
Bioorg Med Chem 19: 5023-30 (2011)
Kochi Medical School
Evaluation of influence of Ap4A analogues on Fhit-positive HEK293T cells; cytotoxicity and ability to induce apoptosis.EBI
Bioorg Med Chem 19: 5053-60 (2011)
Polish Academy of Sciences
Thrombin inhibitors with lipid peroxidation and lipoxygenase inhibitory activities.EBI
Bioorg Med Chem Lett 21: 4705-9 (2011)
University of Ljubljana
New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.EBI
Bioorg Med Chem Lett 21: 4695-7 (2011)
Philipps University Marburg
6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators.EBI
Bioorg Med Chem Lett 21: 4891-9 (2011)
Lundbeck Research Usa
Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.EBI
J Med Chem 54: 5307-19 (2011)
University of Louisiana At Monroe
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.EBI
Bioorg Med Chem 19: 4413-20 (2011)
Nanjing University
A mechanism-based potent sirtuin inhibitor containing Ne-thiocarbamoyl-lysine (TuAcK).EBI
Bioorg Med Chem Lett 21: 4753-7 (2011)
University of Akron
Synthesis and antiglycation potentials of bergenin derivatives.EBI
Bioorg Med Chem Lett 21: 4928-31 (2011)
India Institute of Chemical Technology
Bioactive sulfoximines: syntheses and properties of Vioxx analogs.EBI
Bioorg Med Chem Lett 21: 4888-90 (2011)
Rwth Aachen University
Discovery of novel fatty acid synthase (FAS) inhibitors based on the structure of ketoaceyl synthase (KS) domain.EBI
Bioorg Med Chem Lett 21: 4742-4 (2011)
Sichuan University
New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds.EBI
J Med Chem 54: 5694-711 (2011)
Universit£
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.EBI
J Med Chem 54: 5722-36 (2011)
Universita` Degli Studi Di Perugia
Synthesis, kinetic evaluation and cell-based analysis of C-alkylated isofagomines as chaperones of ╬▓-glucocerebrosidase.BDB
Chembiochem 12: 2151-4 (2011)
University of British Columbia
Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors.EBI
Bioorg Med Chem Lett 21: 4844-6 (2011)
East China Normal University
Click to a focused library of benzyl 6-triazolo(hydroxy)benzoic glucosides: novel construction of PTP1B inhibitors on a sugar scaffold.EBI
Eur J Med Chem 46: 4212-8 (2011)
East China University of Science and Technology
Fluorescent derivatives ofs receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.EBI
J Med Chem 54: 5858-67 (2011)
Universita` Degli Studi Di Bari Aldo Moro
Design and discovery of a selective small molecule¿ opioid antagonist (2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242).EBI
J Med Chem 54: 5868-77 (2011)
Pfizer
Discovery of vinylogous carbamates as a novel class ofß-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.EBI
Bioorg Med Chem 19: 4454-9 (2011)
Soochow University
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.EBI
Bioorg Med Chem Lett 21: 4909-12 (2011)
Novartis Institutes For Biomedical Research
Pyridine-derived ?-secretase modulators.EBI
Bioorg Med Chem Lett 21: 4832-5 (2011)
Glaxosmithkline Pharmaceuticals
Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B.EBI
Bioorg Med Chem Lett 21: 4798-803 (2011)
Northeastern Ohio Universities Colleges of Medicine and Pharmacy
Discovery of indazoles as inhibitors of Tpl2 kinase.EBI
Bioorg Med Chem Lett 21: 4758-61 (2011)
Pfizer
Peptoid ligands that bind selectively to phosphoproteins.EBI
Bioorg Med Chem Lett 21: 4960-4 (2011)
The Scripps Research Institute
Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARa antagonists.EBI
Bioorg Med Chem Lett 21: 4869-72 (2011)
Universit£
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.EBI
Bioorg Med Chem 19: 4460-72 (2011)
Universit£
Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.EBI
Bioorg Med Chem 19: 4482-98 (2011)
Takeda Pharmaceutical
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.EBI
Bioorg Med Chem 19: 4544-51 (2011)
Universit£
Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.EBI
Bioorg Med Chem Lett 21: 4860-4 (2011)
Philipps University Marburg
Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.EBI
Bioorg Med Chem Lett 21: 4857-9 (2011)
Pfizer
Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists.EBI
Bioorg Med Chem Lett 21: 4913-8 (2011)
Dr. Reddy'S Laboratories
Synthesis, molecular modeling and biological evaluation ofß-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents.EBI
Bioorg Med Chem 19: 4513-9 (2011)
Nanjing University
Arthrinins A-D: novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp.EBI
Bioorg Med Chem 19: 4644-51 (2011)
Heinrich Heine Universit£T
Development of 3-substituted-androsterone derivatives as potent inhibitors of 17ß-hydroxysteroid dehydrogenase type 3.EBI
Bioorg Med Chem 19: 4652-68 (2011)
Chuq (Chul)-Research Center
Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket.EBI
Bioorg Med Chem Lett 21: 4836-43 (2011)
Vitae Pharmaceuticals
Synthesis of 6-[¹8F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18 kDa with PET.EBI
Bioorg Med Chem Lett 21: 4819-22 (2011)
Cea
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.EBI
Eur J Med Chem 46: 3976-85 (2011)
University of Kwazulu-Natal
A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system.BDB
J Enzyme Inhib Med Chem 27: 5-11 (2012)
Chulalongkorn University
In vitro effects of some drugs on human erythrocyte glutathione reductase.BDB
J Enzyme Inhib Med Chem 27: 18-23 (2012)
Ataturk University
Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): a focus on selectivity over arginase.BDB
J Enzyme Inhib Med Chem 27: 24-8 (2012)
Christian-Albrechts-University
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.EBI
J Med Chem 54: 5485-97 (2011)
National Human Genome Research Institute
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.EBI
J Med Chem 54: 5283-95 (2011)
Sunovion Pharmaceuticals
Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.EBI
Bioorg Med Chem 19: 4499-505 (2011)
Imir K.U. Leuven
Discovery of selective indole-based prostaglandin D2 receptor antagonist.EBI
Bioorg Med Chem 19: 4574-88 (2011)
Minase Research Institute
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.EBI
Bioorg Med Chem Lett 21: 4422-8 (2011)
Merck Research Laboratories
C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.EBI
Bioorg Med Chem Lett 21: 4465-70 (2011)
Chinese Academy of Sciences
Discovery and synthesis of a new class of opioid ligand having a 3-azabicyclo[3.1.0]hexane core. An example of a 'magic methyl' giving a 35-fold improvement in binding.EBI
Bioorg Med Chem Lett 21: 4608-11 (2011)
Pfizer
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2.EBI
Bioorg Med Chem Lett 21: 4429-35 (2011)
Merck Research Laboratories
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.EBI
Bioorg Med Chem 19: 4635-43 (2011)
St. Jude Children'S Research Hospital
Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors.EBI
Bioorg Med Chem 19: 4437-44 (2011)
Shandong University
Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup.EBI
Bioorg Med Chem Lett 21: 4436-40 (2011)
Glaxosmithkline
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.EBI
Bioorg Med Chem Lett 21: 4409-15 (2011)
Glaxosmithkline
Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.EBI
Bioorg Med Chem Lett 21: 4397-9 (2011)
Nci-Frederick
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region.EBI
Bioorg Med Chem Lett 21: 4533-9 (2011)
Boehringer Ingelheim Pharmaceuticals
Structure-activity study on a series ofa-glutamic acid scaffold based compounds as new ADAMTS inhibitors.EBI
Bioorg Med Chem Lett 21: 4457-61 (2011)
Chinese Academy of Sciences
Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents.EBI
J Med Chem 54: 5373-84 (2011)
Universidade Do Porto (Cequimed-Up)
Synthesis and in vitro biological evaluation of carbonyl group-containing analogues fors1 receptors.EBI
J Med Chem 54: 5362-72 (2011)
Washington University
Binding ofa,a-disubstituted amino acids to arginase suggests new avenues for inhibitor design.EBI
J Med Chem 54: 5432-43 (2011)
Drexel University
Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.BDB
Biochemistry 50: 6867-78 (2011)
Astrazeneca Pharmaceuticals
New anthranilic acid based antagonists with high affinity and selectivity for the human cholecystokinin receptor 1 (hCCK1-R).EBI
J Med Chem 54: 5769-85 (2011)
University of Trieste
The lipogenesis pathway as a cancer target.EBI
J Med Chem 54: 5615-38 (2011)
Wayne State University
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.EBI
J Med Chem 54: 5320-34 (2011)
University of Namur
Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors.EBI
Bioorg Med Chem 19: 4529-35 (2011)
Tsinghua University
Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 4490-7 (2011)
National Tsing Hua University
Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.EBI
Bioorg Med Chem Lett 21: 4577-80 (2011)
Suven Life Sciences
Photosynthesis-Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates.EBI
Bioorg Med Chem Lett 21: 4564-7 (2011)
University of Pardubice
Synthesis and Na+/H+ exchanger inhibitory activity of benzoylguanidine derivatives.EBI
Eur J Med Chem 46: 4107-16 (2011)
China Pharmaceutical University
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.EBI
Bioorg Med Chem 19: 4626-34 (2011)
Novartis Institutes For Biomedical Research
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.EBI
Bioorg Med Chem Lett 21: 4652-7 (2011)
Merck Research Laboratories
Design-driven LO: the discovery of new ultra long acting dibasicß2-adrenoceptor agonists.EBI
Bioorg Med Chem Lett 21: 4612-6 (2011)
Astrazeneca
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain.EBI
Eur J Med Chem 46: 4078-88 (2011)
Chosun University
N-ß-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.EBI
Bioorg Med Chem Lett 21: 4447-50 (2011)
Universidad Nacional De La Plata
Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 4507-11 (2011)
Nerviano Medical Sciences
In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).EBI
J Med Chem 54: 5576-82 (2011)
Harvard Medical School
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.EBI
Bioorg Med Chem Lett 21: 4528-32 (2011)
Memorial Sloan-Kettering Cancer Center
Benzisothiazolones as modulators of macrophage migration inhibitory factor.EBI
Bioorg Med Chem Lett 21: 4545-9 (2011)
Yale University
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.EBI
Bioorg Med Chem Lett 21: 4556-60 (2011)
Astrazeneca R&D Boston
Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.BDB
Biochemistry 50: 6678-88 (2011)
University of Colorado Denver
Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment.EBI
J Nat Prod 74: 1590-6 (2011)
Pharmamar Sau
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.EBI
Bioorg Med Chem 19: 6654-7 (2011)
University of California
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.EBI
Bioorg Med Chem Lett 21: 4602-7 (2011)
Pfizer
Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives.EBI
Eur J Med Chem 46: 4676-81 (2011)
University of Lisbon
Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.EBI
J Med Chem 54: 5532-9 (2011)
Shandong University
Rational design of potent, small, synthetic allosteric inhibitors of thrombin.EBI
J Med Chem 54: 5522-31 (2011)
Virginia Commonwealth University
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability.EBI
J Med Chem 54: 5174-84 (2011)
Amgen
Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.EBI
Eur J Med Chem 46: 4042-9 (2011)
Taipei Medical University
Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.EBI
J Med Chem 54: 5498-507 (2011)
Academy of Sciences of The Czech Republic
Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?EBI
J Med Chem 54: 5737-46 (2011)
University of Antwerp (Ua)
Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.BDB
Biochemistry 50: 6642-54 (2011)
Glaxosmithkline
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).EBI
Bioorg Med Chem 19: 4173-82 (2011)
National Health Research Institutes
Synthesis, biological evaluation and docking studies of octane-carboxamide based renin inhibitors with extended segments toward S3' site of renin.EBI
Bioorg Med Chem 19: 4238-49 (2011)
China Pharmaceutical University
Synthesis of an aryloxy oxo pyrimidinone library that displays ALK-selective inhibition.EBI
Bioorg Med Chem Lett 21: 4592-6 (2011)
St. Jude Children'S Research Hospital
Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for I¿B kinase-beta (IKKß) inhibitors and virtual screening based on it.EBI
Eur J Med Chem 46: 3942-52 (2011)
China Pharmaceutical University
Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.EBI
J Med Chem 54: 5468-77 (2011)
University of California
From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).EBI
J Med Chem 54: 5836-57 (2011)
Amgen
Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents-synthesis, antiproliferative activity and inhibition of tubulin polymerization.EBI
Bioorg Med Chem 19: 4183-91 (2011)
Westphalian Wilhelms-University
Discovery of imidazo[1,2-b]pyridazines as IKKß inhibitors. Part 3: exploration of effective compounds in arthritis models.EBI
Bioorg Med Chem Lett 21: 4550-5 (2011)
Daiichi Sankyo
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38a MAP kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 4633-7 (2011)
Bristol-Myers Squibb
Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A.EBI
Eur J Med Chem 46: 3986-95 (2011)
Washington University
The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.EBI
Bioorg Med Chem Lett 21: 4597-601 (2011)
Biogen Idec
Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.EBI
Eur J Med Chem 46: 4010-24 (2011)
Universit£
Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.EBI
J Med Chem 54: 5583-91 (2011)
University of Athens
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice.EBI
J Med Chem 54: 5444-53 (2011)
Universita Degli Studi Di Siena
Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.EBI
Bioorg Med Chem 19: 4227-37 (2011)
Csir Biosciences
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist.EBI
Bioorg Med Chem Lett 21: 4622-8 (2011)
Msd
Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides.EBI
Eur J Med Chem 46: 3832-44 (2011)
Veterans Affairs Medical Center
Identification of a small-molecule inhibitor of DNA topoisomerase II by proteomic profiling.BDB
Chem Biol 18: 743-51 (2011)
Riken Advanced Science Institute
Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.BDB
Chem Biol 18: 722-32 (2011)
Stanford University
Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.BDB
J Enzyme Inhib Med Chem 27: 365-9 (2012)
Agri Ibrahim Cecen University
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.EBI
J Med Chem 54: 5562-75 (2011)
Neuraxon
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.EBI
J Med Chem 54: 5349-61 (2011)
University of Vienna
Selectivity of kinase inhibitor fragments.EBI
J Med Chem 54: 5131-43 (2011)
Glaxosmithkline
The discovery of long-acting saligeninß2 adrenergic receptor agonists incorporating hydantoin or uracil rings.EBI
Bioorg Med Chem 19: 4192-201 (2011)
Glaxosmithkline
Generation of 'Unnatural Natural Product' library and identification of a small molecule inhibitor of XIAP.EBI
Bioorg Med Chem 19: 4377-85 (2011)
Keio University
Design, synthesis and biological evaluation of 2'-deoxy-2',2'-difluoro-5-halouridine phosphoramidate ProTides.EBI
Bioorg Med Chem 19: 4338-45 (2011)
Cardiff University
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold.EBI
Bioorg Med Chem Lett 21: 4164-9 (2011)
Broad Institute of Harvard and Mit
N-Acylhydrazones as inhibitors of PDE10A.EBI
Bioorg Med Chem Lett 21: 4155-9 (2011)
Omeros
Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.EBI
Bioorg Med Chem Lett 21: 4306-9 (2011)
Sun Yat-Sen University
Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.EBI
Bioorg Med Chem Lett 21: 4141-5 (2011)
Bristol-Myers Squibb Research and Development
Indolin-2-one p38a inhibitors I: design, profiling and crystallographic binding mode.EBI
Bioorg Med Chem Lett 21: 4130-3 (2011)
RhôNe-Poulenc Rorer
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-ß type 1 receptor kinase inhibitors.EBI
Eur J Med Chem 46: 3917-25 (2011)
Ewha Womans University
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.EBI
J Med Chem 54: 5540-61 (2011)
Glaxosmithkline
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening.EBI
J Med Chem 54: 5454-67 (2011)
Universita Degli Studi Di Modena E Reggio Emilia
Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.EBI
J Med Chem 54: 5165-73 (2011)
Universidade Do Porto
Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).EBI
J Med Chem 54: 5403-13 (2011)
University of Arizona
Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists.EBI
Bioorg Med Chem 19: 4257-73 (2011)
Glaxosmithkline
Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD-1).EBI
Bioorg Med Chem Lett 21: 4146-9 (2011)
Bristol-Myers Squibb
Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parameters.EBI
Bioorg Med Chem Lett 21: 4276-80 (2011)
Boehringer Ingelheim Pharmaceuticals
Structural investigation into the inhibitory mechanisms of indomethacin and its analogues towards human glyoxalase I.EBI
Bioorg Med Chem Lett 21: 4243-7 (2011)
Sun Yat-Sen University
New, potent, selective, and short-acting peptidic V1a receptor agonists.EBI
J Med Chem 54: 4388-98 (2011)
Ferring Research Institute
Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators.EBI
J Med Chem 54: 5070-81 (2011)
Lundbeck Research Usa
Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.EBI
ACS Med Chem Lett 2: 363-367 (2011)
Calvin College
Synthesis of novel inhibitors of ?-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.EBI
Bioorg Med Chem 19: 4286-94 (2011)
University of Karachi
Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.EBI
Bioorg Med Chem 19: 4330-7 (2011)
National Institute On Drug Abuse and The National Institute On Alcohol Abuse and Alcoholism
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.EBI
Bioorg Med Chem Lett 21: 4224-7 (2011)
Universidad De Santiago De Compostela
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.EBI
Bioorg Med Chem Lett 21: 4150-4 (2011)
Pfizer
Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors.EBI
Bioorg Med Chem Lett 21: 4203-5 (2011)
Keimyung University
Arylamides hybrids of two high-affinitys2 receptor ligands as tools for the development of PET radiotracers.EBI
Eur J Med Chem 46: 4733-41 (2011)
Universit£
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.EBI
Bioorg Med Chem Lett 21: 4228-32 (2011)
Nycomed
Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design.EBI
Eur J Med Chem 46: 3909-16 (2011)
Dalian University of Technology
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.EBI
Bioorg Med Chem 19: 4366-76 (2011)
Shandong University
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation.EBI
Eur J Med Chem 46: 3867-76 (2011)
University of Lille
Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.EBI
J Med Chem 54: 4773-80 (2011)
Merck Research Laboratories
Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.EBI
J Med Chem 54: 4880-95 (2011)
Merck Research Laboratories
Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.EBI
Bioorg Med Chem Lett 21: 4296-300 (2011)
Birla Institute of Technology
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP.EBI
Bioorg Med Chem Lett 21: 4332-6 (2011)
Sanford-Burnham Medical Research Institute
Synthesis and biological evaluation of (±)-3-(2-(2-fluorobenzyloxy) naphthalen-6-yl)-2-aminopropanoic acid derivatives as novel PTP1B inhibitors.EBI
Eur J Med Chem 46: 3630-8 (2011)
Yanbian University
Acetaldehyde-derived modifications on cytosolic human carbonic anhydrases.BDB
J Enzyme Inhib Med Chem 26: 862-70 (2011)
University of Tampere and Tampere University Hospital
Side chain SAR of bicyclicß-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.EBI
Bioorg Med Chem Lett 21: 4267-70 (2011)
Merck Research Labs
Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 4343-8 (2011)
Glaxosmithkline
New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.EBI
J Med Chem 54: 5205-20 (2011)
Universit£
Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.EBI
J Med Chem 54: 5265-9 (2011)
Universidad Complutense De Madrid
Triptolide directly inhibits dCTP pyrophosphatase.BDB
Chembiochem 12: 1767-73 (2011)
Yale University
Optimisation of a novel series of selective CNS penetrant CB(2) agonists.EBI
Bioorg Med Chem Lett 21: 4284-7 (2011)
Pfizer
Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore.EBI
Bioorg Med Chem Lett 21: 4337-42 (2011)
Tokyo University of Science
Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3).EBI
Bioorg Med Chem Lett 21: 4255-8 (2011)
Merck Research Laboratories
Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening.EBI
Bioorg Med Chem Lett 21: 4238-42 (2011)
Indiana University
In vitro inhibition ofa-carbonic anhydrase isozymes by some phenolic compounds.EBI
Bioorg Med Chem Lett 21: 4259-62 (2011)
Gumushane University
Selective non zinc binding inhibitors of MMP13.EBI
Bioorg Med Chem Lett 21: 4215-9 (2011)
Astrazeneca
Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens.EBI
J Nat Prod 74: 1636-9 (2011)
The University of Mississippi
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.EBI
ACS Med Chem Lett 2: 91-96 (2011)
Pfizer
Synthesis and Biological Evaluation of N-Fluoroalkyl and 2-Fluoroalkoxy Substituted Aporphines: Potential PET Ligands for Dopamine D(2) Receptors.EBI
ACS Med Chem Lett 2: 189-194 (2011)
Harvard Medical School
Synthesis and evaluation of fluorescent heterocyclic aminoadamantanes as multifunctional neuroprotective agents.EBI
Bioorg Med Chem 19: 3935-44 (2011)
North-West University
Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold.EBI
Bioorg Med Chem 19: 3906-18 (2011)
Chinese Academy of Sciences
Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis.EBI
Bioorg Med Chem 19: 3956-64 (2011)
University of California
Facile fabrication of promising protein tyrosine phosphatase (PTP) inhibitor entities based on 'clicked' serine/threonine-monosaccharide hybrids.EBI
Bioorg Med Chem 19: 3892-900 (2011)
East China University of Science and Technology
Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.EBI
Bioorg Med Chem Lett 21: 4325-8 (2011)
Korea Institute of Science and Technology
Inhibition of the cellular function of perforin by 1-amino-2,4-dicyanopyrido[1,2-a]benzimidazoles.EBI
Bioorg Med Chem 19: 4091-100 (2011)
University of Auckland
Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.EBI
Bioorg Med Chem 19: 3983-94 (2011)
La Trobe University
DNA-instructed acyl transfer reactions for the synthesis of bioactive peptides.EBI
Bioorg Med Chem Lett 21: 4993-7 (2011)
Humboldt Universit£T Zu Berlin
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.EBI
Eur J Med Chem 46: 3590-607 (2011)
Jagiellonian University Medical College
Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.EBI
Bioorg Med Chem Lett 21: 4363-5 (2011)
Merck
Synthesis and evaluation of highly potent GABA(A) receptor antagonists based on gabazine (SR-95531).EBI
Bioorg Med Chem Lett 21: 4252-4 (2011)
University College London
Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors.EBI
Eur J Med Chem 46: 3690-5 (2011)
Umm Al-Qura University
Synthesis and antiviral evaluation ofa-L-2'-deoxythreofuranosyl nucleosides.EBI
Eur J Med Chem 46: 3704-13 (2011)
University of Gent
Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).EBI
J Med Chem 54: 5031-47 (2011)
Myrexis
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.EBI
J Med Chem 54: 5082-96 (2011)
Merck Frosst Centre For Therapeutic Research
Biophysical mapping of the adenosine A2A receptor.EBI
J Med Chem 54: 4312-23 (2011)
Heptares Therapeutics
Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: a highly potent orally available CCR5 selective antagonist.EBI
Bioorg Med Chem 19: 4028-42 (2011)
Ono Pharmaceutical
Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor.EBI
J Med Chem 54: 4998-5012 (2011)
Takeda Pharmaceutical
Synthesis and evaluation of 5-substituted 2'-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis.EBI
J Med Chem 54: 4847-62 (2011)
Katholieke Universiteit Leuven
Design driven HtL: The discovery and synthesis of new high efficacyß2-agonists.EBI
Bioorg Med Chem Lett 21: 4027-31 (2011)
Astrazeneca
Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt).EBI
J Med Chem 54: 5154-64 (2011)
The Hebrew University of Jerusalem
Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.EBI
J Med Chem 54: 5260-4 (2011)
Chosun University
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.EBI
J Med Chem 54: 4752-72 (2011)
Novartis Institutes For Biomedical Research
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophrenia.EBI
J Med Chem 54: 4536-47 (2011)
Pfizer
The relevance of higher plants in lead compound discovery programs.EBI
J Nat Prod 74: 1539-55 (2011)
The Ohio State University
Imidazolopiperazines: hit to lead optimization of new antimalarial agents.EBI
J Med Chem 54: 5116-30 (2011)
Genomics Institute of The Novartis Research Foundation
N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIa and induce apoptosis in G1/S phase.EBI
J Med Chem 54: 5013-30 (2011)
National Institute of Pharmaceutical Education and Research (NIPER)
Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands.EBI
ACS Med Chem Lett 2: 337-341 (2011)
Nci-Frederick
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1.EBI
Bioorg Med Chem Lett 21: 4104-7 (2011)
Kitasato University
Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors.EBI
Bioorg Med Chem Lett 21: 3918-22 (2011)
Technical University of Denmark
Combined SVM-based and docking-based virtual screening for retrieving novel inhibitors of c-Met.EBI
Eur J Med Chem 46: 3675-80 (2011)
Sichuan University
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons.EBI
Bioorg Med Chem Lett 21: 4023-6 (2011)
Kitasato University
A diazen-1-ium-1,2-diolated nitric oxide donor ester prodrug of 3-(4-hydroxymethylphenyl)-4-(4-methanesulfonylphenyl)-5H-furan-2-one: synthesis, biological evaluation and nitric oxide release studies.EBI
Bioorg Med Chem Lett 21: 3951-6 (2011)
University of Alberta
Discovery of S1P agonists with a dihydronaphthalene scaffold.EBI
Bioorg Med Chem Lett 21: 3885-9 (2011)
Ono Pharmaceutical
Phenyl isoxazole voltage-gated sodium channel blockers: structure and activity relationship.EBI
Bioorg Med Chem Lett 21: 3871-6 (2011)
Astrazeneca
Flavonoids as inhibitors of human CD38.EBI
Bioorg Med Chem Lett 21: 3939-42 (2011)
University of Strasburg
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.EBI
Bioorg Med Chem Lett 21: 4066-71 (2011)
Pfizer
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.EBI
Bioorg Med Chem Lett 21: 3943-6 (2011)
Chinese Academy of Medical Sciences and Peking Union Medical College
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.EBI
Bioorg Med Chem Lett 21: 3976-81 (2011)
Merck Frosst Centre For Therapeutic Research
New class of acetylcholinesterase inhibitors from the stem bark of Knema laurina and their structural insights.EBI
Bioorg Med Chem Lett 21: 4097-103 (2011)
University Putra Malaysia
7-Substituted pterins provide a new direction for ricin A chain inhibitors.EBI
Eur J Med Chem 46: 3608-15 (2011)
University of Texas At Austin
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.EBI
Bioorg Med Chem Lett 21: 4059-65 (2011)
Pfizer
Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1.EBI
J Med Chem 54: 5229-36 (2011)
The Scripps Research Institute
Identification of a naturally occurring quinazolin-4(3H)-one firefly luciferase inhibitor.EBI
J Nat Prod 74: 1500-2 (2011)
Merlion Pharmaceuticals
The use of novel C-methylated spermidine derivatives to investigate the regulation of polyamine metabolism.EBI
J Med Chem 54: 4611-8 (2011)
University of Eastern Finland
Pyridazine-derived ?-secretase modulators.EBI
Bioorg Med Chem Lett 21: 4016-9 (2011)
Glaxosmithkline Pharmaceuticals
Enantioselective binding of second generation pyrrolobenzoxazepinones to the catalytic ternary complex of HIV-1 RT wild-type and L100I and K103N drug resistant mutants.EBI
Bioorg Med Chem Lett 21: 3935-8 (2011)
2-Universit£
Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.EBI
Bioorg Med Chem Lett 21: 4054-8 (2011)
Genentech
In vitro effects of some anabolic compounds on erythrocyte carbonic anhydrase I and II.BDB
J Enzyme Inhib Med Chem 27: 208-10 (2012)
Balikesir University
Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products.BDB
J Enzyme Inhib Med Chem 27: 43-50 (2012)
AtatŘrk University
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.EBI
J Med Chem 54: 4694-720 (2011)
S*Bio
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.EBI
J Med Chem 54: 4781-92 (2011)
Cephalon
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.EBI
J Med Chem 54: 4427-45 (2011)
Amgen
Identification of new inhibitors of protein kinase R guided by statistical modeling.EBI
Bioorg Med Chem Lett 21: 4108-14 (2011)
Weill Cornell Medical College
Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors.EBI
Bioorg Med Chem Lett 21: 3877-80 (2011)
Cephalon
Irreversible Nek2 kinase inhibitors with cellular activity.EBI
J Med Chem 54: 4133-46 (2011)
University of California
Block of the hERG channel by bupivacaine: Electrophysiological and modeling insights towards stereochemical optimization.EBI
Eur J Med Chem 46: 3486-98 (2011)
University of Geneva
Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa.EBI
J Med Chem 54: 4806-14 (2011)
University of Rouen
Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.EBI
J Med Chem 54: 4474-89 (2011)
Clermont Universite£
Peptidomimetic inhibitors of bacterial peptide deformylase.EBI
Bioorg Med Chem Lett 21: 4032-5 (2011)
Vernalis (R&D)
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.EBI
Bioorg Med Chem Lett 21: 3970-5 (2011)
Merck Frosst Centre For Therapeutic Research
Structure-based optimization of click-based histone deacetylase inhibitors.EBI
Eur J Med Chem 46: 3190-200 (2011)
Nankai University
Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.EBI
Eur J Med Chem 46: 3428-33 (2011)
Zhejiang University
Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.BDB
Bioorg Chem 39: 138-42 (2011)
Medical University of Lodz
Synthesis and discovery of novel hexacyclic cage compounds as inhibitors of acetylcholinesterase.EBI
Bioorg Med Chem Lett 21: 3997-4000 (2011)
Universiti Sains Malaysia
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability.EBI
Bioorg Med Chem Lett 21: 4036-40 (2011)
Dana-Farber Cancer Institute
Triazole-linked reduced amide isosteres: an approach for the fragment-based drug discovery of anti-Alzheimer's BACE1 inhibitors.EBI
Bioorg Med Chem Lett 21: 3992-6 (2011)
Virginia Tech
Generation of novel radiolabeled opiates through site-selective iodination.EBI
Bioorg Med Chem Lett 21: 4001-4 (2011)
Memorial Sloan-Kettering Cancer Center
8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.EBI
Eur J Med Chem 46: 3474-85 (2011)
North-West University
Preliminary evaluation of a 3H imidazoquinoline library as dual TLR7/TLR8 antagonists.EBI
Bioorg Med Chem 19: 3801-11 (2011)
University of Kansas
Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.EBI
Bioorg Med Chem 19: 3732-8 (2011)
University of Florida
Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 3856-60 (2011)
Pfizer
Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.EBI
Bioorg Med Chem Lett 21: 4013-5 (2011)
Second Military Medical University
Recent progress in biological activities of synthesized phenothiazines.EBI
Eur J Med Chem 46: 3179-89 (2011)
The Medical University of Silesia
Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.EBI
Eur J Med Chem 46: 3455-61 (2011)
Universit£
Synthesis and biological evaluation of conformationally flexible as well as restricted dimers of monastrol and related dihydropyrimidones.EBI
Eur J Med Chem 46: 3274-81 (2011)
Indian Institute of Chemical Technology
Selective kainate receptor (GluK1) ligands structurally based upon 1H-cyclopentapyrimidin-2,4(1H,3H)-dione: synthesis, molecular modeling, and pharmacological and biostructural characterization.EBI
J Med Chem 54: 4793-805 (2011)
University of Copenhagen
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.EBI
J Nat Prod 74: 1370-8 (2011)
University of Yaounde
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.EBI
J Med Chem 54: 4187-206 (2011)
Neurogen
Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D.EBI
ACS Med Chem Lett 2: 154-159 (2012)
University of Pittsburgh
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.EBI
Bioorg Med Chem 19: 3757-68 (2011)
Universita' Di Firenze
Triazoles as¿-secretase modulators.EBI
Bioorg Med Chem Lett 21: 4083-7 (2011)
Merck Research Laboratories
Progress in structure based drug design for G protein-coupled receptors.EBI
J Med Chem 54: 4283-311 (2011)
Heptares Therapeutics
Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.EBI
J Med Chem 54: 4172-86 (2011)
Universite£? De Rennes 1
Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases?EBI
J Med Chem 54: 4508-22 (2011)
East China University of Science and Technology
Structure-based design of novel boronic acid-based inhibitors of autotaxin.EBI
J Med Chem 54: 4619-26 (2011)
The Netherlands Cancer Institute
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.EBI
Bioorg Med Chem 19: 3777-86 (2011)
University of Lille
3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities.EBI
Bioorg Med Chem Lett 21: 3511-4 (2011)
India Institute of Technology and Science
Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperone.EBI
Bioorg Med Chem Lett 21: 3557-62 (2011)
Pfizer
Carbonic anhydrase I and II inhibition with natural products: caffeine and piperine.BDB
J Enzyme Inhib Med Chem 27: 97-100 (2012)
Gitam University
Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.EBI
J Med Chem 54: 4928-32 (2011)
The University of Texas M.D. Anderson Cancer Center
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives.EBI
J Med Chem 54: 4735-51 (2011)
Amgen
Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor.BDB
Chem Biol 18: 569-79 (2011)
University of Edinburgh
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.BDB
Chem Biol Drug Des 78: 191-8 (2011)
University of California San Diego
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.EBI
J Med Chem 54: 4092-108 (2011)
Merck Research Laboratories
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.EBI
Bioorg Med Chem Lett 21: 3627-31 (2011)
Pfizer
Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties.EBI
Bioorg Med Chem Lett 21: 3828-31 (2011)
Abbott Laboratories
Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphEBI
J Med Chem 54: 4638-58 (2011)
S*Bio
Structure-based design of potent aromatase inhibitors by high-throughput docking.EBI
J Med Chem 54: 4006-17 (2011)
Universita` Di Modena E Reggio Emilia
Syntheses of cellotriose and cellotetraose analogues as transition state mimics for mechanistic studies of cellulases.EBI
Bioorg Med Chem 19: 3812-30 (2011)
Hirosaki University
Methyl-monofluorination of ibuprofen selectively increases its inhibitory activity toward cyclooxygenase-1 leading to enhanced analgesic activity and reduced gastric damage in vivo.EBI
Bioorg Med Chem Lett 21: 3578-82 (2011)
Shanghai Haini Pharmaceutical
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors.EBI
Bioorg Med Chem Lett 21: 3738-42 (2011)
H. Lundbeck
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3603-7 (2011)
Msd
Tetrazine-trans-cyclooctene ligation for the rapid construction of integrinavß3 targeted PET tracer based on a cyclic RGD peptide.EBI
Bioorg Med Chem Lett 21: 5011-4 (2011)
University of Delaware
Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.EBI
Eur J Med Chem 46: 3348-61 (2011)
Medical University of Lodz
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.EBI
Eur J Med Chem 46: 3339-47 (2011)
Sun Yat-Sen University
Site-directed mutagenesis provides insights into the selective binding of trityl derivatives to Plasmodium falciparum dUTPase.EBI
Eur J Med Chem 46: 3309-14 (2011)
Instituto De Parasitolog£A Y Biomedicina L£Pez-Neyra
Bivalent dopamine D2 receptor ligands: synthesis and binding properties.EBI
J Med Chem 54: 4896-903 (2011)
Friedrich-Alexander University
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity.EBI
J Med Chem 54: 4590-9 (2011)
Universita Di Napoli Federico Ii
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.EBI
J Med Chem 54: 4548-58 (2011)
University of California San Francisco
Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.EBI
J Med Chem 54: 4839-46 (2011)
Kyoto University
Novel flavonoids with antiproliferative activities against breast cancer cells.EBI
J Med Chem 54: 4339-49 (2011)
University of California Davis
Inhibitors of histone demethylases.EBI
Bioorg Med Chem 19: 3625-36 (2011)
University of Copenhagen
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3813-7 (2011)
Msd
Design and synthesis of protein kinase Ca activators based on 'out of pocket' interactions.EBI
Bioorg Med Chem Lett 21: 3587-90 (2011)
Riken Advanced Science Institute
Synthesis and antityrosinase activities of alkyl 3,4-dihydroxybenzoates.EBI
J Agric Food Chem 59: 6645-9 (2011)
Xiamen University
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.EBI
Pest Manag Sci 67: 1457-67 (2011)
Csiro Materials Science and Engineering and Csiro Food and Nutritional Sciences
Glucosides with cyclic diarylpolynoid as novel C-aryl glucoside SGLT2 inhibitors.EBI
Bioorg Med Chem Lett 21: 3759-63 (2011)
Green Cross
Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.EBI
Bioorg Med Chem Lett 21: 3616-21 (2011)
Astrazeneca R&D Charnwood
Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor.EBI
Bioorg Med Chem Lett 21: 3608-12 (2011)
University of Strasburg
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.EBI
J Med Chem 54: 4324-38 (2011)
Soochow University College of Pharmaceutical Sciences
Development ofß-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics.EBI
J Med Chem 54: 4659-69 (2011)
University of Colorado At Boulder
Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.EBI
J Med Chem 54: 4490-507 (2011)
Zafes/Liff/Goethe University Frankfurt
Fenretinide derivatives act as disrupters of interactions of serum retinol binding protein (sRBP) with transthyretin and the sRBP receptor.EBI
J Med Chem 54: 4378-87 (2011)
National University of Ireland
Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors.EBI
Bioorg Med Chem 19: 3312-9 (2011)
Tsinghua University
Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 3648-53 (2011)
Bayer Pharma
Structure-activity relationship studies to probe the phosphoprotein binding site on the carboxy terminal domains of the breast cancer susceptibility gene 1.EBI
J Med Chem 54: 4264-8 (2011)
University of Nebraska Medical Center
Toluidinesulfonamide hypoxia-induced factor 1 inhibitors: alleviating drug-drug interactions through use of PubChem data and comparative molecular field analysis guided synthesis.EBI
J Med Chem 54: 3982-6 (2011)
Elara Pharmaceuticals
Discovery of 3,5-Diamino-1,2,4-triazole Ureas as Potent Anaplastic Lymphoma Kinase Inhibitors.EBI
ACS Med Chem Lett 2: 379-384 (2011)
TBA
New 5-deoxyflavonoids and their inhibitory effects on protein tyrosine phosphatase 1B (PTP1B) activity.EBI
Bioorg Med Chem 19: 3378-83 (2011)
Chosun University
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).EBI
Bioorg Med Chem 19: 3320-40 (2011)
University of California
Discovery of a potent and selective small molecule hGPR91 antagonist.EBI
Bioorg Med Chem Lett 21: 3596-602 (2011)
Advinus Therapeutics
Evaluation of sulfatase-directed quinone methide traps for proteomics.EBI
Bioorg Med Chem 20: 622-7 (2012)
Bielefeld University
CXCR3 antagonists: quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors.EBI
Bioorg Med Chem 19: 3384-93 (2011)
Vu University Amsterdam
The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.EBI
Bioorg Med Chem Lett 21: 3712-4 (2011)
Kosan Biosciences
Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 1.EBI
Bioorg Med Chem Lett 21: 3805-8 (2011)
Merck Research Laboratories
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement.EBI
Bioorg Med Chem Lett 21: 3726-9 (2011)
Elan Pharmaceuticals
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.EBI
Bioorg Med Chem Lett 21: 3591-5 (2011)
Universit£
Synthesis, biological activity and HPLC validation of 1,2,3,4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors.EBI
Eur J Med Chem 46: 3250-7 (2011)
Medical University
Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1.EBI
Bioorg Med Chem 19: 3394-401 (2011)
Eberhard Karls University Tuebingen
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.EBI
Bioorg Med Chem 19: 3416-24 (2011)
University of Mansoura
Synthesis and biological evaluation of loxoprofen derivatives.EBI
Bioorg Med Chem 19: 3299-311 (2011)
Kumamoto University
Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.EBI
Bioorg Med Chem 19: 3434-43 (2011)
National Institute On Drug Abuse and The National Institute On Alcohol Abuse and Alcoholism
Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain.EBI
Bioorg Med Chem Lett 21: 3676-81 (2011)
Xenon Pharmaceuticals
Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3632-6 (2011)
The Scripps Research Institute
Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.EBI
Bioorg Med Chem Lett 21: 3809-12 (2011)
Dong-A Pharm.
Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).EBI
Bioorg Med Chem Lett 21: 3654-7 (2011)
Universidad Nacional De Colombia
Synthesis, activity, and structural analysis of novel ?-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.EBI
J Med Chem 54: 4462-73 (2011)
National Cancer Institute-Frederick
Discovery and characterization of small molecule inhibitors of the BET family bromodomains.EBI
J Med Chem 54: 3827-38 (2011)
Glaxosmithkline
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.EBI
J Med Chem 54: 4207-18 (2011)
Takeda Pharmaceutical
Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase.BDB
J Chem Biol 3: 175-87 (2010)
Svims University
Structure-based lead identification of ATP-competitive MK2 inhibitors.EBI
Bioorg Med Chem Lett 21: 3818-22 (2011)
Merck Research Laboratories
Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.EBI
Bioorg Med Chem Lett 21: 3708-11 (2011)
Pfizer
Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors.EBI
Bioorg Med Chem Lett 21: 3823-7 (2011)
Merck Research Laboratories
Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors.EBI
Bioorg Med Chem Lett 21: 3774-9 (2011)
Amgen
N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.EBI
J Med Chem 54: 4247-63 (2011)
Westphalian Wilhelms-University
Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans.EBI
Bioorg Med Chem 19: 3474-82 (2011)
Catholic University of C£Rdoba
Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 3788-93 (2011)
Chugai Pharmaceutical
High affinity sialoside ligands of myelin associated glycoprotein.EBI
Bioorg Med Chem Lett 21: 5045-9 (2011)
The Scripps Research Institute
Identification and synthesis of N'-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase.EBI
Bioorg Med Chem Lett 21: 3749-54 (2011)
Chinese Academy of Sciences
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant.EBI
Bioorg Med Chem Lett 21: 3743-8 (2011)
Ariad Pharmaceuticals
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.EBI
J Med Chem 54: 4721-34 (2011)
Baylor College of Medicine
Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins.EBI
J Med Chem 54: 4923-7 (2011)
Kyoto University
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.EBI
J Nat Prod 74: 1201-6 (2011)
Gifu Pharmaceutical University
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿.EBI
J Med Chem 54: 4219-33 (2011)
Pfizer
Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors.EBI
Bioorg Med Chem 19: 3361-6 (2011)
Peking University
Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (s) receptor ligands modulates off-target activity and subtype selectivity.EBI
Bioorg Med Chem Lett 21: 3622-6 (2011)
The University of Sydney
Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.EBI
Bioorg Med Chem Lett 21: 3755-8 (2011)
Chonnam National University
Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.EBI
Bioorg Med Chem 19: 3585-94 (2011)
Duquesne University
1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.EBI
Bioorg Med Chem 19: 3451-61 (2011)
Glaxosmithkline
New 2-thioether-substituted apomorphines as potent and selective dopamine D2 receptor agonists.EBI
Eur J Med Chem 46: 2992-9 (2011)
University of Tartu
From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons.EBI
Bioorg Med Chem Lett 21: 3658-63 (2011)
Boehringer Ingelheim (Canada)
Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.EBI
Bioorg Med Chem Lett 21: 3237-42 (2011)
F. Hoffmann-La Roche
Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action.EBI
Bioorg Med Chem Lett 21: 3216-21 (2011)
U.O. Oculistica Az. Usl 3
Toward self-adjuvanting subunit vaccines: model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines.EBI
Bioorg Med Chem Lett 21: 3232-6 (2011)
University of Kansas
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties.EBI
Eur J Med Chem 46: 3000-12 (2011)
Universidade Federal Do Rio De Janeiro
Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.EBI
J Med Chem 54: 4350-64 (2011)
University of Illinois At Chicago
Hippolides A-H, acyclic manoalide derivatives from the marine sponge Hippospongia lachne.EBI
J Nat Prod 74: 1248-54 (2011)
Second Military Medical University
Docking and SAR studies of D- and L-isofagomine isomers as humanß-glucocerebrosidase inhibitors.EBI
Bioorg Med Chem 19: 3558-68 (2011)
University of Toyama
Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.EBI
Bioorg Med Chem Lett 21: 3243-7 (2011)
Institute For Neurodegenerative Disorders
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.EBI
Eur J Med Chem 46: 3118-23 (2011)
University of Santo Tomas
Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.EBI
J Med Chem 54: 3854-65 (2011)
The University of Western Ontario
Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 3286-9 (2011)
Novartis Institutes For Biomedical Research
Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.EBI
J Med Chem 54: 3650-60 (2011)
Peking University
Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds.EBI
J Nat Prod 74: 1401-7 (2011)
Universita Di Salerno
Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile.EBI
J Med Chem 54: 3756-67 (2011)
Glaxosmithkline
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.EBI
J Med Chem 54: 3661-8 (2011)
Sanford-Burnham Medical Research Institute
Cryptocaryols A-H,a-pyrone-containing 1,3-polyols from Cryptocarya sp. implicated in stabilizing the tumor suppressor Pdcd4.EBI
J Nat Prod 74: 1015-20 (2011)
National Cancer Institute-Frederick
Identification and characterization of new inhibitors of fungal homoserine kinase.BDB
Chembiochem 12: 1179-82 (2011)
Mcmaster University
Design and evaluation of 3-aminopyrazolopyridinone kinase inhibitors inspired by the natural product indirubin.EBI
Bioorg Med Chem 19: 3569-78 (2011)
The Institute of Cancer Research
Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound.EBI
Bioorg Med Chem 19: 3502-11 (2011)
Washington University
Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes.EBI
Bioorg Med Chem Lett 21: 3290-6 (2011)
Merck Research Laboratories
Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.EBI
Bioorg Med Chem Lett 21: 3301-6 (2011)
Astrazeneca
Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists.EBI
Bioorg Med Chem Lett 21: 3297-300 (2011)
Abbott Laboratories
Non-oxime pyrazole based inhibitors of B-Raf kinase.EBI
Bioorg Med Chem Lett 21: 3488-92 (2011)
Array Biopharma
Evaluation of in vitro effects of some analgesic drugs on erythrocyte and recombinant carbonic anhydrase I and II.BDB
J Enzyme Inhib Med Chem 27: 37-42 (2012)
Balikesir University
Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus.EBI
J Med Chem 54: 3963-72 (2011)
The Skaggs Institute For Chemical Biology
Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study.EBI
J Med Chem 54: 3675-85 (2011)
Hannover Medical School
Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design.EBI
Bioorg Med Chem Lett 21: 3335-41 (2011)
Trinity College
Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.EBI
Bioorg Med Chem Lett 21: 3435-8 (2011)
University of Pennsylvania
Design, synthesis and pharmacological evaluation of spirocyclics(1) receptor ligands with exocyclic amino moiety (increased distance 1).EBI
Bioorg Med Chem 19: 3141-51 (2011)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.EBI
Bioorg Med Chem Lett 21: 3407-10 (2011)
H. Lundbeck
Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence.EBI
Bioorg Med Chem Lett 21: 3354-7 (2011)
Bayer Yakuhin
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications.EBI
Eur J Med Chem 46: 2797-806 (2011)
Universit£
Design, synthesis and inhibition activity of a novel cyclic enediyne amino acid conjugates against MPtpA.EBI
Bioorg Med Chem 19: 3274-9 (2011)
India Institute of Technology and Science
Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors.EBI
Bioorg Med Chem 19: 3249-54 (2011)
Kakatiya University
Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR)a-selective agonists.EBI
Bioorg Med Chem 19: 3183-91 (2011)
Okayama University
Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast.EBI
Bioorg Med Chem Lett 21: 3307-12 (2011)
Heriot-Watt University
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphated-ester modifications as selective agonists of the P2Y(4) receptor.EBI
J Med Chem 54: 4018-33 (2011)
Niddk
Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD).EBI
J Med Chem 54: 3492-9 (2011)
University of East Anglia
Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity.BDB
J Med Chem 54: 4034-41 (2011)
Vernalis (R&D)
Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.EBI
Bioorg Med Chem 19: 3242-8 (2011)
Universit£T Leipzig
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.EBI
Bioorg Med Chem Lett 21: 3457-61 (2011)
RhôNe-Poulenc Rorer
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity.EBI
Bioorg Med Chem Lett 21: 3399-403 (2011)
Astrazeneca Pharmaceuticals
Dual IGF-1R/SRC inhibitors based on a N'-aroyl-2-(1H-indol-3-yl)-2-oxoacetohydrazide structure.EBI
Eur J Med Chem 46: 2759-69 (2011)
Technische Universit£T Braunschweig
Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.BDB
J Enzyme Inhib Med Chem 26: 341-9 (2011)
Suven Life Sciences
Nobilamides A-H, long-acting transient receptor potential vanilloid-1 (TRPV1) antagonists from mollusk-associated bacteria.EBI
J Med Chem 54: 3746-55 (2011)
University of Utah
Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor.EBI
J Med Chem 54: 3480-91 (2011)
Vu University Medical Center
Acenaphtho[1,2-b]pyrrole-based selective fibroblast growth factor receptors 1 (FGFR1) inhibitors: design, synthesis, and biological activity.EBI
J Med Chem 54: 3732-45 (2011)
East China University of Science and Technology
Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.EBI
J Med Chem 54: 3935-49 (2011)
University of Washington
Biological evaluation of novel benzisoxazole derivatives as PPARd agonists.EBI
Bioorg Med Chem 19: 3255-64 (2011)
Nippon Chemiphar
Virtual screening and further development of novel ALK inhibitors.EBI
Bioorg Med Chem 19: 3086-95 (2011)
Pharmadesign
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.EBI
Bioorg Med Chem 19: 3105-19 (2011)
Universit£
Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.EBI
Bioorg Med Chem 19: 3039-53 (2011)
Astrazeneca Research and Development
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors.EBI
Bioorg Med Chem Lett 21: 3404-6 (2011)
Pfizer
New indole amide derivatives as potent CRTH2 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3471-4 (2011)
Merck Frosst
Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life.EBI
Bioorg Med Chem Lett 21: 3467-70 (2011)
Astrazeneca R&D
Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity.EBI
Bioorg Med Chem Lett 21: 3411-6 (2011)
Pfizer
3-Amino-pyrazolo[3,4-d]pyrimidines as p38a kinase inhibitors: design and development to a highly selective lead.EBI
Bioorg Med Chem Lett 21: 3452-6 (2011)
Roche Palo Alto
Synthesis and bioactivity of new Finasteride conjugate.EBI
Bioorg Med Chem Lett 21: 3439-42 (2011)
Jilin University
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands fora1-adrenoceptor subtypes.EBI
Eur J Med Chem 46: 2676-90 (2011)
Universit£
Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity.EBI
Bioorg Med Chem 19: 3156-72 (2011)
The University of Tokyo
Asymmetric synthesis and biological evaluations of (+)- and (-)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels.EBI
Bioorg Med Chem Lett 21: 3317-9 (2011)
Ajinomoto Pharmaceuticals
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.EBI
Bioorg Med Chem Lett 21: 3384-9 (2011)
Amgen
3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists.EBI
Bioorg Med Chem Lett 21: 3390-4 (2011)
Merck Research Laboratories
Synthesis, biological evaluation, and docking studies of gigantol analogs as calmodulin inhibitors.EBI
Eur J Med Chem 46: 2699-708 (2011)
Universidad Nacional Aut£Noma De M£Xico
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.EBI
Eur J Med Chem 46: 2617-29 (2011)
Universit£
New halogenated phenylcoumarins as tyrosinase inhibitors.EBI
Bioorg Med Chem Lett 21: 3342-5 (2011)
Universidad De Santiago De Compostela
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 2806-11 (2011)
Glaxosmithkline
Thiazolylmethyl ortho-substituted phenyl glucoside library as novel C-aryl glucoside SGLT2 inhibitors.EBI
Eur J Med Chem 46: 2662-75 (2011)
Green Cross Corporation Research Center
Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC.BDB
Chem Biol 18: 454-63 (2011)
University of Oklahoma
Resorcylic acid lactones with cytotoxic and NF-¿B inhibitory activities and their structure-activity relationships.EBI
J Nat Prod 74: 1126-31 (2011)
University of North Carolina At Greensboro
Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.EBI
Drug Metab Dispos 39: 1294-302 (2011)
Radboud University Nijmegen Medical Centre
Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1).EBI
Bioorg Med Chem Lett 21: 2945-8 (2011)
Gyeongsang National University
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.EBI
Bioorg Med Chem Lett 21: 2898-905 (2011)
National University of Singapore
Azaphilones and p-terphenyls from the mangrove endophytic fungus Penicillium chermesinum (ZH4-E2) isolated from the South China Sea.EBI
J Nat Prod 74: 997-1002 (2011)
Sun Yat-Sen University
Estrogenic activity of chemical constituents from Tephrosia candida.EBI
J Nat Prod 74: 937-42 (2011)
National Research Centre
Xylarenones C-E from an endophytic fungus isolated from Alibertia macrophylla.EBI
J Nat Prod 74: 1353-7 (2011)
Universidade Estadual Paulista
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 2832-5 (2011)
Merck Frosst Center For Therapeutic Research
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.EBI
Bioorg Med Chem Lett 21: 2836-9 (2011)
Merck Frosst Centre For Therapeutic Research
MMP-13 selectivea-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteres.EBI
Bioorg Med Chem Lett 21: 2820-2 (2011)
Pfizer
A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.EBI
Bioorg Med Chem Lett 21: 2877-81 (2011)
Astrazeneca R&D
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.EBI
Bioorg Med Chem Lett 21: 3050-6 (2011)
Genzyme
HCV-NS3/4A protease inhibitory iridoid glucosides and dimeric foliamenthoic acid derivatives from Anarrhinum orientale.EBI
J Nat Prod 74: 943-8 (2011)
Cairo University
Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.EBI
J Med Chem 54: 3973-6 (2011)
The University of Tennessee
Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.EBI
J Med Chem 54: 3977-81 (2011)
The Hebrew University of Jerusalem
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.BDB
ChemMedChem 6: 1011-6 (2011)
Zydus Research Centre
Crystal structure of the Ca2+/calmodulin-dependent protein kinase kinase in complex with the inhibitor STO-609.BDB
J Biol Chem 286: 22570-9 (2011)
Riken Systems and Structural Biology Center
Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.EBI
Bioorg Med Chem 19: 2797-807 (2011)
Chinese Academy of Medical Sciences & Peking Union Medical College
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.EBI
Bioorg Med Chem Lett 21: 2850-4 (2011)
College of Pharmacy Kyung Hee University
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.EBI
J Med Chem 54: 3109-52 (2011)
F. Hoffmann-La Roche
Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.EBI
ACS Med Chem Lett 2: 113-118 (2011)
Sanford-Burnham Medical Research Institute
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.EBI
J Med Chem 54: 4042-56 (2011)
Instituto De Qui£?Mica Medica-Csic
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.EBI
J Nat Prod 74: 1009-14 (2011)
Institute of Medicinal Plant Development
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase.EBI
ACS Med Chem Lett 2: 63-67 (2011)
University of Minnesota
N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.EBI
Bioorg Med Chem 19: 2850-8 (2011)
Jagiellonian University Medical College
Development and SAR of functionally selective allosteric modulators of GABAA receptors.EBI
Bioorg Med Chem 19: 2927-38 (2011)
Astrazeneca
Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.EBI
Eur J Med Chem 46: 2609-16 (2011)
Sun Yat-Sen University
Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches.EBI
Eur J Med Chem 46: 2469-76 (2011)
Gyeongsang National University (Gnu)
Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.EBI
Eur J Med Chem 46: 2541-5 (2011)
Upres Ea 4021 Biomol�Cules Et Th�Rapies Anti-Tumorales
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.EBI
J Med Chem 54: 3524-48 (2011)
University of Virginia
N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.EBI
J Med Chem 54: 3581-94 (2011)
National Institute On Drug Abuse-Intramural Research Program
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidine.EBI
J Med Chem 54: 3426-35 (2011)
Genentech
Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.EBI
Bioorg Med Chem 19: 2859-78 (2011)
Universit£T Regensburg
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.EBI
Bioorg Med Chem 19: 2835-41 (2011)
Kyoto Pharmaceutical University
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 2958-61 (2011)
Astrazeneca R&D Boston
Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.EBI
Bioorg Med Chem Lett 21: 2986-90 (2011)
National Cancer Institute-Frederick
Synthesis and evaluation of dual site inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase.EBI
Bioorg Med Chem Lett 21: 5092-7 (2011)
University of Canterbury
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.EBI
Bioorg Med Chem Lett 21: 2911-5 (2011)
Merck
MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amides.EBI
Bioorg Med Chem Lett 21: 2823-5 (2011)
Pfizer
Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.EBI
Bioorg Med Chem 19: 2817-22 (2011)
University of Alberta
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H.EBI
Bioorg Med Chem Lett 21: 2840-4 (2011)
Chungnam National University
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.EBI
Bioorg Med Chem Lett 21: 3002-6 (2011)
Korea Institute of Science and Technology
Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin.EBI
Bioorg Med Chem Lett 21: 5098-101 (2011)
The University of Utah
SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 2890-3 (2011)
Merck Research Laboratories
SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration.EBI
J Med Chem 54: 3564-74 (2011)
East China University of Science and Technology
Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.EBI
Bioorg Med Chem Lett 21: 2916-20 (2011)
Nanjing University
Cyclic lactam hybrida-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.EBI
Bioorg Med Chem Lett 21: 3099-102 (2011)
University of Arizona
Discovery of small molecule human FPR1 receptor antagonists.EBI
Bioorg Med Chem Lett 21: 2991-7 (2011)
Astrazeneca
Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.EBI
J Med Chem 54: 3549-63 (2011)
University of Texas M. D. Anderson Cancer Center
Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.EBI
J Med Chem 54: 3206-21 (2011)
H. Lundbeck
Gambogic acid, a natural product inhibitor of Hsp90.EBI
J Nat Prod 74: 1085-92 (2011)
Oklahoma State University
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.EBI
Bioorg Med Chem 19: 2842-9 (2011)
University of Crete
Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.EBI
Bioorg Med Chem 19: 2808-16 (2011)
Harvard Medical School
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.EBI
Bioorg Med Chem Lett 21: 3037-40 (2011)
Glaxosmithkline
Discovery of new nanomolar peroxisome proliferator-activated receptor κ activators via elaborate ligand-based modeling.EBI
Eur J Med Chem 46: 2513-29 (2011)
Universiti Sains Malaysia
HIF-1a inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.EBI
Eur J Med Chem 46: 2386-96 (2011)
Dongguk University-Seoul
Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted κ receptor agonists: fine tuning of the dihedral angle of the ethylenediamine pharmacophore.EBI
Eur J Med Chem 46: 1972-82 (2011)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Synthesis and biological evaluation of novel 4-benzylpiperazine ligands for sigma-1 receptor imaging.EBI
Bioorg Med Chem 19: 2911-7 (2011)
Key Laboratory of Radiopharmaceuticals (Beijing Normal University)
New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein.EBI
Bioorg Med Chem Lett 21: 2949-52 (2011)
Chinese Academy of Sciences
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.EBI
Eur J Med Chem 46: 2453-62 (2011)
Universit£
Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.EBI
J Med Chem 54: 3200-5 (2011)
Chinese Academy of Sciences
Aromatic radiofluorination and biological evaluation of 2-aryl-6-[18F]fluorobenzothiazoles as a potential positron emission tomography imaging probe for ?-amyloid plaques.EBI
Bioorg Med Chem 19: 2980-90 (2011)
Seoul National University Bundang Hospital
Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-relateda-glucosidase inhibitors and liver X receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3041-5 (2011)
The University of Tokyo
Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.EBI
J Med Chem 54: 2823-38 (2011)
Shandong University
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.EBI
J Agric Food Chem 59: 4860-7 (2011)
University of California
Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.EBI
J Med Chem 54: 3779-92 (2011)
Uppsala University
Novel potent and selectives ligands: evaluation of their agonist and antagonist properties.EBI
J Med Chem 54: 3669-73 (2011)
University of Catania
Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson's disease-associated protein.EBI
Bioorg Med Chem Lett 21: 2953-7 (2011)
Inje University
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT2-selective agonists.EBI
J Med Chem 54: 3436-44 (2011)
Takeda Pharmaceutical
Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.EBI
Bioorg Med Chem 19: 3005-21 (2011)
Dainippon Sumitomo Pharma
NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.EBI
Bioorg Med Chem Lett 21: 2969-74 (2011)
Nerviano Medical Sciences
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.EBI
Bioorg Med Chem Lett 21: 3088-91 (2011)
Chonnam National University
Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.EBI
Bioorg Med Chem Lett 21: 2975-9 (2011)
Ecole Nationale Sup£Rieure De Chimie De Montpellier
Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1.EBI
Bioorg Med Chem Lett 21: 2998-3001 (2011)
National Institute of Radiological Sciences
Novel benzo[b]thiophene derivatives as new potential antidepressants with rapid onset of action.EBI
J Med Chem 54: 3086-90 (2011)
University of Navarra
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68).EBI
J Med Chem 54: 2738-44 (2011)
University of Ferrara
Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.EBI
J Med Chem 54: 2646-57 (2011)
Universitat De Barcelona
Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1).EBI
J Med Chem 54: 3163-74 (2011)
University of Innsbruck
Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.EBI
J Med Chem 54: 3306-18 (2011)
University of Michigan
Extending SAR of bile acids as FXR ligands: discovery of 23-N-(carbocinnamyloxy)-3a,7a-dihydroxy-6a-ethyl-24-nor-5β-cholan-23-amine.EBI
Bioorg Med Chem 19: 2650-8 (2011)
Universit£
Synthesis and pharmacological evaluation of thieno[2,3-b]pyridine derivatives as novel c-Src inhibitors.EBI
Bioorg Med Chem 19: 2517-28 (2011)
Institut De Recherches Servier
Synthesis, modelling and kinetic assays of potent inhibitors of purple acid phosphatase.EBI
Bioorg Med Chem Lett 21: 3092-4 (2011)
The University of Queensland
1,5-Substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability.EBI
Bioorg Med Chem Lett 21: 3095-8 (2011)
Pfizer
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.EBI
Eur J Med Chem 46: 2170-84 (2011)
Universit£
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.EBI
Bioorg Med Chem 19: 2582-8 (2011)
Sanford-Burnham Medical Research Institute
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists.EBI
Bioorg Med Chem Lett 21: 3163-7 (2011)
Msd
Triamino pyrimidines and pyridines as histamine H(4) receptor modulators.EBI
Bioorg Med Chem Lett 21: 3113-6 (2011)
Johnson & Johnson Pharmaceutical Research & Development
Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.EBI
Bioorg Med Chem Lett 21: 2962-5 (2011)
Key Laboratory of Radiopharmaceuticals (Beijing Normal University)
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.EBI
Bioorg Med Chem Lett 21: 3172-6 (2011)
Merck Research Laboratories
Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4).EBI
J Med Chem 54: 3331-47 (2011)
University of Glasgow
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor.EBI
J Med Chem 54: 2602-9 (2011)
University Medical Centre Ljubljana
Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.BDB
J Biol Chem 286: 18756-65 (2011)
Takeda Pharmaceutical
Biological evaluation of 3'-O-alkylated analogs of salacinol, the role of hydrophobic alkyl group at 3' position in the side chain on thea-glucosidase inhibitory activity.EBI
Bioorg Med Chem Lett 21: 3159-62 (2011)
Kinki University
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.EBI
Eur J Med Chem 46: 2243-51 (2011)
Universidad Aut£Noma Del Estado De Morelos
Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors.EBI
Eur J Med Chem 46: 2295-309 (2011)
I2Bm
On a possible neutral charge state for the catalytic dyad inß-secretase when bound to hydroxyethylene transition state analogue inhibitors.EBI
J Med Chem 54: 3081-5 (2011)
Universidad De Santiago De Compostela
Studies of O,O-dimethyl ?-(2,4-dichlorophenoxyacetoxy)ethylphosphonate (HW02) as a new herbicide. 1. Synthesis and herbicidal activity of HW02 and analogues as novel inhibitors of pyruvate dehydrogenase complex.EBI
J Agric Food Chem 59: 4801-13 (2011)
Central China Normal University
Revisiting glitazars: thiophene substituted oxazole containinga-ethoxy phenylpropanoic acid derivatives as highly potent PPARa/¿ dual agonists devoid of adverse effects in rodents.EBI
Bioorg Med Chem Lett 21: 3103-9 (2011)
Zydus Research Centre
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).EBI
Bioorg Med Chem Lett 21: 3152-8 (2011)
National Human Genome Research Institute
Chiral sulfoxides as metabolites of 2-thioimidazole-based p38a mitogen-activated protein kinase inhibitors: enantioselective synthesis and biological evaluation.EBI
J Med Chem 54: 3283-97 (2011)
Eberhard-Karls-University Tu£Bingen
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors.EBI
J Med Chem 54: 2952-60 (2011)
Pfizer
Developing potent human uric acid transporter 1 (hURAT1) inhibitors.EBI
J Med Chem 54: 2701-13 (2011)
University of Colorado Anschutz Medical Campus
Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1).EBI
J Med Chem 54: 2680-6 (2011)
Nas of Ukraine
Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction.EBI
Drug Metab Dispos 39: 1188-95 (2011)
Amgen
A novel family of insect-selective peptide neurotoxins targeting insect large-conductance calcium-activated K+ channels isolated from the venom of the theraphosid spider Eucratoscelus constrictus.EBI
Mol Pharmacol 80: 1-13 (2011)
University of Technology Sydney
Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.EBI
J Med Chem 54: 3393-417 (2011)
Pfizer
Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.EBI
J Med Chem 54: 2924-32 (2011)
Wayne State University
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket.EBI
J Med Chem 54: 2727-37 (2011)
Rutgers University
Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.EBI
J Med Chem 54: 2915-23 (2011)
Friedrich-Alexander University
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control.EBI
Bioorg Med Chem Lett 21: 3134-41 (2011)
Arena Pharmaceuticals
Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA ands receptor antagonists.EBI
Eur J Med Chem 46: 2157-69 (2011)
Westf£Lischen Wilhelms-Universit£T M£Nster
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.EBI
J Med Chem 54: 2714-26 (2011)
University of Michigan
Selenophene-containing inhibitors of type IIA bacterial topoisomerases.EBI
J Med Chem 54: 3418-25 (2011)
Achillion Pharmaceuticals
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.EBI
J Med Chem 54: 2610-26 (2011)
University of Siena
Local structural changes, global data views: graphical substructure-activity relationship trailing.EBI
J Med Chem 54: 2944-51 (2011)
Rheinische Friedrich-Wilhelms-Universita£T
Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.EBI
J Med Chem 54: 2933-43 (2011)
National Cancer Institute-Frederick
Synthesis and evaluation of arylquinones as BACE1 inhibitors,β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.EBI
Bioorg Med Chem Lett 21: 2183-7 (2011)
Universidad Complutense
Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series.EBI
Bioorg Med Chem Lett 21: 2207-11 (2011)
Astrazeneca
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.EBI
Bioorg Med Chem Lett 21: 2192-7 (2011)
Washington University
Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.EBI
Bioorg Med Chem Lett 21: 2224-8 (2011)
Sanofi-Aventis
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1.EBI
Bioorg Med Chem 19: 3717-31 (2011)
Albert-Ludwigs-University of Freiburg
Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.EBI
Eur J Med Chem 46: 2206-16 (2011)
Universit£
Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.EBI
Bioorg Med Chem Lett 21: 2216-9 (2011)
Stony Brook University
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.EBI
Bioorg Med Chem Lett 21: 2330-4 (2011)
Merck Research Laboratories
Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1.EBI
Bioorg Med Chem Lett 21: 2244-51 (2011)
Sanofi-Aventis R&D
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.EBI
Eur J Med Chem 46: 2011-21 (2011)
Chinese Academy of Sciences
Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.EBI
Eur J Med Chem 46: 2141-6 (2011)
University of Lisbon
Jak1 has a dominant role over Jak3 in signal transduction through ╬│c-containing cytokine receptors.BDB
Chem Biol 18: 314-23 (2011)
University of Luxembourg
Oxamic acid analogues as LDH-C4-specific competitive inhibitors.BDB
J Enzyme Inhib Med Chem 26: 579-86 (2011)
Instituto PolitÚcnico Nacional
Amidine-oximes: reactivators for organophosphate exposure.EBI
J Med Chem 54: 3319-30 (2011)
Human Biomolecular Research Institute
Isolation and structure of homotemsirolimuses A, B, and C.EBI
J Nat Prod 74: 547-53 (2011)
Wyeth Research
Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4.EBI
J Med Chem 54: 3260-7 (2011)
University of Pennsylvania
Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrEBI
J Med Chem 54: 3368-85 (2011)
Pfizer
Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.EBI
J Med Chem 54: 2687-700 (2011)
National Institute of Mental Health
Identification, characterization, and implications of species-dependent plasma protein binding for the oral Hedgehog pathway inhibitor vismodegib (GDC-0449).EBI
J Med Chem 54: 2592-601 (2011)
Genentech
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors.EBI
Bioorg Med Chem 19: 2633-40 (2011)
Ewha Womans University
The synthesis and evaluation of indolylureas as PKCa inhibitors.EBI
Bioorg Med Chem 19: 2742-50 (2011)
Procter & Gamble Pharmaceuticals
Identification of potent, soluble, and orally active TRPV1 antagonists.EBI
Bioorg Med Chem Lett 21: 2559-63 (2011)
Msd
Aza-annulation on the 16-dehydropregnenolone, via tandem intermolecular aldol process and intramolecular Michael addition.EBI
Bioorg Med Chem Lett 21: 2232-7 (2011)
Central Drug Research Institute
New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.EBI
Eur J Med Chem 46: 2193-205 (2011)
Cnrs
Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.EBI
J Med Chem 54: 3037-50 (2011)
University of California
17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure-activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors.EBI
Bioorg Med Chem 19: 2428-42 (2011)
Takeda Pharmaceutical
Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues.EBI
Bioorg Med Chem 19: 2168-75 (2011)
Catholic University of Daegu
Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and A β-aggregation inhibitors.EBI
Bioorg Med Chem 19: 2269-81 (2011)
University of Waterloo
Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.EBI
Bioorg Med Chem Lett 21: 2274-7 (2011)
University of Kwazulu-Natal
The discovery and synthesis of potent zwitterionic inhibitors of renin.EBI
Bioorg Med Chem Lett 21: 2430-6 (2011)
Merck Frosst Centre For Therapeutic Research
3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-ß.EBI
Bioorg Med Chem Lett 21: 2255-8 (2011)
Glaxosmithkline
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.EBI
Eur J Med Chem 46: 2043-57 (2011)
University of The Pacific
Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.EBI
J Med Chem 54: 2778-91 (2011)
Cardiff University
Reversible competitivea-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.EBI
J Med Chem 54: 2805-22 (2011)
The Scripps Research Institute
N-(4-cyanotetrahydro-2H-pyran-4-yl) and N-(1-cyanocyclohexyl) derivatives of 1,5-diarylpyrazole-3-carboxamides showing high affinity for 18 kDa translocator protein and/or cannabinoid receptors.EBI
J Med Chem 54: 2961-70 (2011)
National Institute of Mental Health
Cytotoxic and NF-κB inhibitory constituents of the stems of Cratoxylum cochinchinense and their semisynthetic analogues.EBI
J Nat Prod 74: 1117-25 (2011)
The Ohio State University
Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.EBI
J Med Chem 54: 2864-77 (2011)
University of Montpellier
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).EBI
J Med Chem 54: 3268-82 (2011)
Achillion Pharmaceuticals
Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adduction.EBI
Drug Metab Dispos 39: 974-83 (2011)
Kalamazoo College
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.EBI
Drug Metab Dispos 39: 1088-96 (2011)
Kanazawa University
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.EBI
Bioorg Med Chem 19: 2242-51 (2011)
Universit£
Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.EBI
Bioorg Med Chem Lett 21: 2229-31 (2011)
The Scripps Research Institute
Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome.EBI
Bioorg Med Chem Lett 21: 2568-72 (2011)
Merck Research Laboratories
Synthesis and evaluation of thiophenyl derivatives as inhibitors of alkaline phosphatase.EBI
Bioorg Med Chem Lett 21: 2297-301 (2011)
Universit£
5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.EBI
Bioorg Med Chem 19: 2478-84 (2011)
Indian Institute of Technology
Using small molecules to target protein phosphatases.EBI
Bioorg Med Chem 19: 2145-55 (2011)
Max Planck Institute of Molecular Physiology
Role of the side chain stereochemistry in thea-glucosidase inhibitory activity of kotalanol, a potent naturala-glucosidase inhibitor.EBI
Bioorg Med Chem 19: 2252-62 (2011)
Kinki University
Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.EBI
Bioorg Med Chem Lett 21: 2309-12 (2011)
Korea Research Institute of Chemical Technology
Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore.EBI
Bioorg Med Chem Lett 21: 2515-20 (2011)
Universit£
Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.EBI
Bioorg Med Chem Lett 21: 2316-9 (2011)
Universit£
Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy.EBI
Bioorg Med Chem Lett 21: 2354-8 (2011)
Merck Research Laboratories
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.EBI
Bioorg Med Chem Lett 21: 2305-8 (2011)
Menarini Ricerche Pomezia
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesia.EBI
Bioorg Med Chem Lett 21: 2359-64 (2011)
Merck Research Laboratories
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.EBI
Bioorg Med Chem Lett 21: 2335-40 (2011)
Array Biopharma
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors.EBI
Eur J Med Chem 46: 2058-65 (2011)
University of Messina
Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors.EBI
Bioorg Med Chem Lett 21: 2264-9 (2011)
Merck Serono
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.EBI
Bioorg Med Chem Lett 21: 2278-82 (2011)
Pfizer
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.EBI
Eur J Med Chem 46: 2224-35 (2011)
Instituto De Qu£Mica M£Dica
Studying synergism of methyl linked cyclohexyl thiophenes with triazole: synthesis and their cdk5/p25 inhibition activity.EBI
Eur J Med Chem 46: 2066-74 (2011)
Dr. Reddy'S Laboratories, Ameerpet, Hyderabad, India.
Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.EBI
Bioorg Med Chem 19: 2211-7 (2011)
Universidad De Buenos Aires
Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection.EBI
Bioorg Med Chem Lett 21: 2389-93 (2011)
Pfizer
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI
Eur J Med Chem 46: 3058-65 (2011)
University of Namur
Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase.EBI
J Med Chem 54: 2891-901 (2011)
University Health Network
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.EBI
J Med Chem 54: 2878-90 (2011)
University of Bonn
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors.EBI
J Med Chem 54: 3051-64 (2011)
Dac
Pyrazolo[4,3-d]pyrimidine bioisostere of roscovitine: evaluation of a novel selective inhibitor of cyclin-dependent kinases with antiproliferative activity.EBI
J Med Chem 54: 2980-93 (2011)
Palacky£? University and Institute of Experimental Botany Ascr
5-Benzamidoisoquinolin-1-ones and 5-(κ-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).EBI
J Med Chem 54: 2049-59 (2011)
University of Bath
Crystal structures of ABL-related gene (ABL2) in complex with imatinib, tozasertib (VX-680), and a type I inhibitor of the triazole carbothioamide class.EBI
J Med Chem 54: 2359-67 (2011)
Oxford University
Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation.EBI
J Med Chem 54: 2165-82 (2011)
Universita` Degli Studi Di Siena
Small-molecule ligands of methyl-lysine binding proteins.EBI
J Med Chem 54: 2504-11 (2011)
University of North Carolina At Chapel Hill
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.EBI
J Med Chem 54: 2994-3010 (2011)
University of Lille
Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.EBI
J Med Chem 54: 2627-45 (2011)
Universidad De Granada
Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors.EBI
J Med Chem 54: 2839-63 (2011)
Central Pharmaceutical Research Institute
Phenoxyacetic acids as PPARd partial agonists: synthesis, optimization, and in vivo efficacy.EBI
Bioorg Med Chem Lett 21: 2345-50 (2011)
Glaxosmithkline
Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor.EBI
Bioorg Med Chem Lett 21: 2365-71 (2011)
Takeda Pharmaceutical
Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition.EBI
Bioorg Med Chem Lett 21: 2460-7 (2011)
Amgen
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.EBI
Bioorg Med Chem Lett 21: 2394-9 (2011)
Amgen
Probing the inhibitor selectivity pocket of human 20?-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis.EBI
Bioorg Med Chem Lett 21: 2564-7 (2011)
Monash University (Parkville Campus)
Synopsis of some recent tactical application of bioisosteres in drug design.EBI
J Med Chem 54: 2529-91 (2011)
Bristol-Myers Squibb Pharmaceutical Research and Development
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.EBI
J Med Chem 54: 2467-76 (2011)
Vrije Universiteit Brussel
A one-pot synthesis and biological activity of ageladine A and analogues.EBI
J Med Chem 54: 2492-503 (2011)
Macquarie University
Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.EBI
J Med Chem 54: 2433-46 (2011)
Hoffmann-La Roche
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.EBI
J Med Chem 54: 2320-30 (2011)
Vertex Pharmaceuticals
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1.EBI
ACS Med Chem Lett 2: 195-200 (2011)
TBA
β-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.EBI
Bioorg Med Chem 19: 2378-91 (2011)
University of Dundee
Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines.EBI
Bioorg Med Chem Lett 21: 2384-8 (2011)
Universit£
Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.EBI
Bioorg Med Chem Lett 21: 2484-8 (2011)
Bristol-Myers Squibb Research and Development
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.EBI
Bioorg Med Chem Lett 21: 2541-6 (2011)
Merck Research Laboratories
Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.EBI
Bioorg Med Chem Lett 21: 2376-9 (2011)
Shaoyang University
Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.EBI
J Med Chem 54: 2039-48 (2011)
Northwestern University
The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.BDB
J Enzyme Inhib Med Chem 26: 245-53 (2011)
University of Defence
The evaluation of inhibitive effectiveness of the tumour necrosis factor-a converting enzyme selective inhibitors by HPLC.BDB
J Enzyme Inhib Med Chem 26: 181-7 (2011)
Huazhong University of Science and Technology
Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties.EBI
J Med Chem 54: 2155-64 (2011)
Sapienza University of Rome
Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agent.EBI
J Med Chem 54: 2127-42 (2011)
Chinese Academy of Sciences
Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.EBI
J Med Chem 54: 2143-54 (2011)
University of Jyva£Skyla£
Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives.EBI
Bioorg Med Chem Lett 21: 2521-6 (2011)
Universit£
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.EBI
J Med Chem 54: 2102-13 (2011)
Universita` Degli Studi Di Firenze
In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.EBI
J Med Chem 54: 2422-32 (2011)
University of Troms£
Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.EBI
Bioorg Med Chem Lett 21: 2497-501 (2011)
Merck Research Laboratories
Discovery of non-glucoside SGLT2 inhibitors.EBI
Bioorg Med Chem Lett 21: 2472-5 (2011)
Amgen
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).EBI
Bioorg Med Chem Lett 21: 2468-71 (2011)
Astrazeneca Charnwood
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.EBI
Bioorg Med Chem Lett 21: 2450-5 (2011)
Genzyme
2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.EBI
Bioorg Med Chem Lett 21: 2597-600 (2011)
Merck Research Laboratories
An expeditious access to 5-pyrimidinol derivatives from cyclic methylglyoxal diadducts, formation of argpyrimidines under physiological conditions and discovery of new CFTR inhibitors.EBI
Eur J Med Chem 46: 1935-41 (2011)
University Joseph Fourier-Grenoble 1/Cnrs
Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.EBI
Eur J Med Chem 46: 1682-93 (2011)
University of Bologna
Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.EBI
Bioorg Med Chem 19: 2298-305 (2011)
Sun Yat-Sen University
Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening.EBI
Bioorg Med Chem Lett 21: 2419-24 (2011)
Bharati Vidyapeeth Deemed University
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.EBI
Bioorg Med Chem Lett 21: 2505-9 (2011)
Charles University
Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells.EBI
Bioorg Med Chem Lett 21: 2445-9 (2011)
Pusan National University
Discovery of non-peptide, small molecule antagonists ofa9a10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.EBI
Bioorg Med Chem Lett 21: 2476-9 (2011)
University of Kentucky
Selectivea-glucosidase substrates and inhibitors containing short aromatic peptidyl moieties.EBI
Bioorg Med Chem Lett 21: 2441-4 (2011)
Seoul National University
SPF32629A and SPF32629B: enantioselective synthesis, determination of absolute configuration, cytotoxicity and antibacterial evaluation.EBI
Eur J Med Chem 46: 1803-12 (2011)
Gvk Biosciences
Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.EBI
Bioorg Med Chem Lett 21: 2554-8 (2011)
Bayer Pharma
Discovery of a potent peptidic cyclophilin A inhibitor Trp-Gly-Pro.EBI
Eur J Med Chem 46: 1701-5 (2011)
Fudan University
Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors.EBI
Eur J Med Chem 46: 1841-8 (2011)
China Pharmaceutical University
Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides.EBI
J Med Chem 54: 2522-6 (2011)
Academy of Sciences of The Czech Republic
Design, synthesis, and evaluation of novel 3,6-diaryl-4-aminoalkoxyquinolines as selective agonists of somatostatin receptor subtype 2.EBI
J Med Chem 54: 2351-8 (2011)
Merck Research Laboratories
Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors.EBI
Bioorg Med Chem Lett 21: 2480-3 (2011)
National Institute of Diabetes and Digestive and Kidney Diseases
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.EBI
Bioorg Med Chem Lett 21: 2400-2 (2011)
University of Minnesota
Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.EBI
Bioorg Med Chem Lett 21: 2425-9 (2011)
Kyoto Pharmaceutical University
Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.EBI
Bioorg Med Chem Lett 21: 2492-6 (2011)
Amgen
Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.EBI
Bioorg Med Chem Lett 21: 2533-6 (2011)
Anacor Pharmaceuticals
Discovery and SAR of spirochromane Akt inhibitors.EBI
Bioorg Med Chem Lett 21: 2410-4 (2011)
Array Biopharma
Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor.EBI
Eur J Med Chem 46: 1713-20 (2011)
Indian Institute of Chemical Biology
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.EBI
Eur J Med Chem 46: 1835-40 (2011)
University of Lille
Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).EBI
J Med Chem 54: 2266-81 (2011)
University of Southampton
Role of metalation in the topoisomerase IIa inhibition and antiproliferation activity of a series ofa-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.EBI
J Med Chem 54: 2391-8 (2011)
Memorial Sloan-Kettering Cancer Center
Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.EBI
J Med Chem 54: 2341-50 (2011)
Vertex Pharmaceuticals
Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR).EBI
Bioorg Med Chem 19: 2368-72 (2011)
The Johns Hopkins University School of Medicine
Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity.EBI
Bioorg Med Chem Lett 21: 1933-6 (2011)
Roche Research Center
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.EBI
Bioorg Med Chem Lett 21: 1942-7 (2011)
Novartis Institutes For Biomedical Research
Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.EBI
Eur J Med Chem 46: 1648-55 (2011)
King Saud University
Glycoglycerolipid analogues inhibit PKC translocation to the plasma membrane and downstream signaling pathways in PMA-treated fibroblasts and human glioblastoma cells, U87MG.EBI
Eur J Med Chem 46: 1827-34 (2011)
University of Milan
Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions.EBI
J Med Chem 54: 2477-91 (2011)
Friedrich-Alexander University
Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis.EBI
J Med Chem 54: 2455-66 (2011)
Korea Advanced Institute of Science and Technology
Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases.EBI
J Med Chem 54: 2022-8 (2011)
Tufts University Sackler School of Graduate Biomedical Sciences
Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.EBI
Eur J Med Chem 46: 1749-56 (2011)
Facult£S Universitaires Notre-Dame De La Paix (Fundp)
Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives.EBI
J Med Chem 54: 2307-19 (2011)
Saarland University
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.EBI
Bioorg Med Chem 19: 2342-8 (2011)
Shandong University
Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.EBI
Bioorg Med Chem 19: 2418-27 (2011)
University of Shizuoka
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.EBI
Bioorg Med Chem 19: 3709-16 (2011)
University of Southampton
2D 3D